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ABSTRACT 
This dissertation focuses on studying the production of two categories of high-value 
compounds in bio organisms. The first group is terpenoid indole alkaloids (TIAs) in plant 
Catharanthus roseus, and the second group is wax esters, one of fatty acid derivatives. 
TIAs belong to secondary metabolites in C. roseus and some of them have wide 
pharmaceutical applications. In particular, vinblastine and vincristine are two TIAs with 
anticancer properties and have been marked and used in chemotherapeutic reagents. The 
biggest issue for TIA production is that the content of those secondary metabolites in plant is 
extremely low. To improve the TIA production, we studied the regulation mechanism of the 
TIA pathway and explored the feasibility of valuable TIA production in hairy root culture. 
Compared with the whole plant, plant tissue culture, such as hairy root culture, has 
many advantages, like fast growth, large-scale cultivation, and ease of genetic engineering.  
But the biggest issue for hairy root is that the vinblastine and vincristine synthetic pathway is 
blocked, mainly one of their precursors, vindoline, can not be synthesized in hairy root. To 
explore whether C. roseus hairy root could produce the intermediates in the vindoline 
pathway by overexpressing the pathway enzymes, we co-expressed the first two genes, 
tabersonine 16-hydrolase (T16H) and 16-O-methyltransferase (16OMT) in the vindoline 
pathway into hairy root. Transcriptional analysis and metabolic profiling were done to 
compare the difference between the parent hairy root lines and the engineered hairy root 
lines.  
For the metabolic profiling, since the standards for those intermediates were not 
available, we prepared in-house standards by expressing the plant genes in Saccharomyces 
cerevisiae, fed substrate, and purified TIA compounds from yeast cell culture. Liquid 
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chromatography (LC) coupled with either photodiode array detector (PDA) or mass 
spectrometry (MS) were applied to isolate and analyze the TIA compounds by their UV-
Visible absorption spectra and molecular weights.  
In addition, fundamental research was done in C. roseus hairy root to study the effects 
of transcription regulators on the transcript levels and metabolite levels of the TIA pathway. 
Two of the seven reported transcription activators of the TIA pathway, octadecanoid-
responsive Catharanthus AP2-domain 2(ORCA3) and MYB-like DNA-binding protein 
(BPF1), were overexpessed in hairy root separately, Two of the transcription repressors, G-
box binding factors (GBF1 and GBF2), were knocked down by RNA interface in hairy root. 
And the transcription analysis and metabolic profiling of the transcription regulator-
engineered hairy root lines were done to see what were the effects caused by those regulators. 
Wax esters have a lot of applications in lubricant, skin care products, cosmetics, 
inking, and coating industries. Currently the main bio source for high-performed wax ester is 
from the seeds of jojoba. The tight supply makes wax esters high-value compounds. To 
reduce the production cost, we introduced the wax ester biosynthetic pathway into an 
oleaginous yeast, Yarrowia lipolytica. The free fatty alcohol, and wax ester were quantified 
in the engineered Y. lipolytica.  
To provide more substrate for wax ester synthesis, we knocked out some genes in the 
substrate competitive pathways, and constructed four strains with different combination of 
knockout genes. To utilize the most abundant fatty acid types in Y. lipolytica, we compared 
three fatty acyl-CoA reductases (FAR), the first enzyme in the wax ester pathway, from 
different species. It was found that those three FARs had different substrate specificity and 
the wax ester production varied a lot in those strains. 
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To solve the plasmid instability issue, we randomly integrated FAR gene and WS 
gene into Y. lipolytica genome, and studied the effect of nitrogen limited fermentation on the 
wax ester production in one of our best strains. 
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CHAPTER I. INTRODUCTION 
Products of interest 
There are two main categories of compounds in my research projects, one is terpenoid 
indole alkaloids, belonging to the secondary metabolites in a medicinal plant, and the other is 
fatty acid derivatives, which are primary metabolites in a few organisms.  
Terpenoid indole alkaloids (TIAs) contain a structural moiety of indole from amino acid 
tryptophan and a structural moiety of terpene from isoprene groups (Figure 1.1). Some of the 
TIAs have significant physiological activity. For examples, ajmaline found in most species of the 
Rauwolfia genus and Catharanthus roseus (C. roseus) is an antiarrhythmic and antihypertension 
agent, vinblastine and vincristine isolated from C. roseus are widely applied in 
chemotherapeutical reagents to treat Hodgkin’s lymphoma, lung cancers and other types of 
diseases. The quantity of the TIA in plants is extremely low, which makes those medicinal 
compounds valuable. To improve the TIA production and reduce production costs, some of my 
collaborated research projects focus on transcription analysis and metabolite profiling of the TIA 
pathway in engineered C. roseus hairy root lines.  
Fatty acids consist of a long hydrocarbonate chain and one or more carboxylic groups. 
Most of the natural fatty acids have the carbon chain lengths from 4 to 22, with 18 most common 
(Figure 1.2). Fatty acids are the main components of oil and fats. Fatty acids and its derivatives 
have overwhelming commercial uses, such as soap, waxes, polishes, leather treating, emulsifiers 
and so on. Wax esters are one type of high valued fatty acid derivatives, and the chemical 
structure is an ester of a fatty acid and a fatty alcohol. My studies focused on producing wax 
esters in a non-native host, oleaginous yeast Yarrowia lipolytica (Y. lipolytica). 
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Production of TIAs in C. roseus 
Vinblastine and vincristine are the two most important TIAs in C. roseus. When 
researchers began to analyze C. roseus in the late 1950’s, vincristine and vinblastine were found 
to be able to lower the number of white cells in blood. Through decades of research, the 
medicinal mechanism of vinblastine and vincristine has been well studied and these two 
compounds are currently widely applied in chemotherapies to treat many types of cancers. To 
decrease their toxicity and explore broader pharmacological applications, several semi-synthetic 
derivatives were synthesized, among which, vindesine and vinorelbine have been marketed. 
Together with vinblastine and vincristine, these four compounds have different pharmaceutical 
profiles and are used to treat different types of cancers [1]. Figure 1.3 shows the structure of 
these four vinca alkalkoids. 
C. roseus produces more than 130 different TIAs, and is the only source for obtaining 
vinblastine and vincristine. The biosynthetic pathway of TIAs in C. roseus is complex and highly 
branched (Figure 1.4). The isolation of vinblastine and vincristine from C. roseus is laborious 
and costly due to their relatively low levels in the plant. Approximately 500 kg of dried leaves 
are needed in order to isolate 1 gram of vinblastine [2]. Research has been focusing on 
production of vinca alkaloids either by fermentation of endophytic fungi in C. roseus or by large-
scale culturing of plant suspension cells, hairy roots, and other tissues.  
Plant endophytic fungi play important roles in plant secondary metabolite biosynthesis. 
Some endophytic fungi produce the same metabolites as their hosts. However no fermentation 
based on plant endophytic fungi has been commercialized due to the low and sometimes unstable 
yields. More than 183 endophytic fungi were isolated from different tissues of C. roseus and 
some of them were reported to possess the ability to produce either vinblastine or vincristine. 
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Among the fungi isolated from Chinese C. roseus, it was reported that one endophytic fungus, 
Fusarium oxysporum, produced vincristine, and another endophytic fungi species, Alternatia sp., 
produced vinblastine. The Fusarium oxysporum isolated from Indian species produced 76 µg 
vinblastine and 67 µg vincristine in one liter of fermentation broth, and the dimers were 
characterized via HPLC, MS and 1H NMR [3]. For Fusarium, the biosynthetic pathways for the 
production of vinblastine and vincristine from tryptophan and geraniol have not been elucidated. 
Biotechnology progress in plant in vitro cell and tissue culture provides alternatives to 
produce valuable secondary metabolites [4]. Suspension cells and hairy roots, being amenable to 
large-scale industrial application, are the two most in-depth studied cultures [5]. Plant suspension 
cells are biosynthetically totipotent with the potential to produce all the compounds in parent 
plants. Rao et al. listed the plant species whose cell cultures produce more secondary metabolites 
than the intact plants do [6]. The bottlenecks of cell culture development are low product yields, 
genetic instability, and metabolite variability [7]. Hairy roots in most cases grow with the similar 
rates as cell culture but with higher biochemical and genetic stability. In addition, since hairy 
roots are differentiated, compartmentation of portions of cellular pathways may assist in the 
production of toxic intermediates and metabolites. They keep most of the properties of the 
natural roots and contain metabolites synthesized in the roots. This distinction is important since 
transport of metabolites to and from other plant tissues is not present in a root culture [8]. 
C. roseus cell suspension and hairy root cultures do not produce the two bisindole 
alkaloids, vinblastine and vincristine, as a result of the inability to synthesize one of the 
monoterpene indole alkaloids (MIA), vindoline (Figure 1.4). Vindoline condenses with another 
MIA, catharanthine, forming the bisindole alkaloids. In suspension cell cultures, transcripts of N-
methyltransferase (NMT), desacetoxyvindoline 4-hydroxylase (D4H) and deacetylvindoline 
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acetyltransferase (DAT) are absent and consequently the biosynthesis of vindoline is blocked [9-
11]. Root cultures lack the idioblast and laticifer, which are specialized cell types for the late 
steps of vindoline synthesis, so vindoline cannot be produced in hairy root cultures as well. A 
comprehensive RNA-seq data from different tissues of C. roseus, including leaf, flower and root, 
also indicated that enzymes involved in the vindoline and vinblastine pathways are restricted to 
aerial tissues [12]. The intermediate metabolite tabersonine in hairy root culture accumulates and 
is converted via the lochnericine and hörhammericine branch, instead of the vindoline branch 
[13]. The high flux through tabersonine in hairy roots indicates the potential of this culture type 
for production of vindoline if an active tabersonine to vindoline pathway could be engineered 
into the roots. 
Elicitation is a common strategy to increase secondary metabolite levels in intact plants, 
plant tissues and cell cultures. Among various elicitors, jasmonic acid, its conjugates and 
precursors, collectively known as jasmonates (JAs), are effective in activating the biosynthesis of 
many plant secondary metabolites through initiating plant defense mechanisms against pathogens 
and herbivores [14]. Various strategies to increase alkaloids levels, including adjusting medium, 
temperature, light, and aeration, have been reviewed [15,16]. Many plant phytohormones and 
elicitors, both biotic and abiotic, have been applied to increase alkaloids accumulation [16,17]. 
In microbial production systems, various metabolic engineering strategies are often 
applied to improve production. In contrast, plant metabolic engineering is still in its infancy and 
many toolkits are needed. Particle bombardment and Agrobacterium-mediated transformation are 
the two frequently used methods to introduce foreign DNA molecules, and protocols have been 
established for transforming Catharanthus roseus (vinca alkaloids producer) [18,19]. Metabolic 
engineering of C. roseus cell suspensions, hairy root cultures and even intact plants has been 
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studied with the aim of increasing TIA accumulation. Overexpression of transcription factors, 
overexpression of a TIA enzyme, or a combination of enzymes has been the main strategies to 
date. Precursor feeding strategies are often combined with these experiments in order to 
determine rate-limiting steps. These efforts often only result in modest improvement of TIA 
accumulation (Table 1.1) since transcriptional regulation is hierarchical and a large portion of the 
regulatory network is still unclear. 
Besides production of valuable secondary metabolites in native organisms, heterologous 
synthesis, mainly in microbes, brings new opportunities and technical challenges. The 
advantages of heterologous synthesis involve: (1) ease of genetic manipulation and culture 
processing in heterologous hosts, (2) lack of complicated regulation belonging to the native 
organisms, and (3) simplified purification process without contamination by structurally similar 
metabolites that exist in the native organisms. Meanwhile, the challenges are also apparent. First 
of all, enabling a heterologous host for producing plant secondary metabolites usually requires 
the expression of multiple genes, and expressing plant-sourced proteins in microbial systems is 
sometimes challenging. Secondly, the accumulation of some intermediates caused by unbalanced 
gene expression may result in a toxicity issue. Furthermore, some metabolites require plant 
organelles for their synthesis, so that an alternative scaffold in the microbial host will have to be 
created. Regardless of these challenges, the rapid development in synthetic biology points out 
additional directions to tackle the challenges in this area, for example, Martin et al. [20] 
developed E. coli strains as platform hosts for the production of terpenoid compounds. 
Heterologous expression of the TIA synthetic pathway in non-native plant hosts and 
microbial hosts is under development and will potentially pave the way to produce interesting 
TIAs from hosts that grow faster and are easier to be cultured. Most of the heterologous 
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expression efforts focused on tryptophan decarboxylase (TDC), strictosidine synthase (STR), and 
strictosidine β-d-glucosidase (SGD), the three enzymes in the upstream of TIA pathway (Figure 
1.4). These three genes were expressed in tobacco suspension cells, tobacco plants, Cinchona 
officinalis hairy root culture, other plant species tissue cultures, yeast and E. coli, individually or 
in combination, with the precursor fed to the culture [17]. Table 1.1 also listed some examples of 
genetic engineering in non-native host. In 2015, as the last two unknown genes in vindoline 
biosynthetic pathway branch, tabersonine 3-oxygenase (T3O) and tabersonine 3-reductase 
(T3R), catalyzing the “hydration” reaction from 16-methoxytabersonine to 16-methoxy-2,3-
dihydro-3-hydroxytabersonine were isolated, De Luca et al. assembled the seven-step pathway 
from tabersonine to vindoline in yeast [21]. By feeding with tabersonine or one of the 
intermediates, 16-methoxytabersonine, the engineered yeast strains were able to accumulate 
vindoline and other intermediates, and secreted 95% of the MIA to the medium. In another 
example, as the genes involved in the upstream secologanin synthetic pathway were all 
characterized in succession, O’Connor’s group introduced the whole pathways in S. cerevisiae 
together with other genetic manipulations to produce the central intermediate, strictosidine, 
without any precursor feeding [22]. 
Regulation of the TIA pathway 
The TIA pathways involve at least 35 intermediates, 30 biosynthetic enzymes, eight 
regulatory genes, and several cellular compartments [23-25]. Perhaps not surprisingly, the 
genetic manipulation of the TIA pathway in C. roseus is rarely successful in increasing the final 
levels of TIA metabolites. Because the TIA pathway is highly regulated, a complete 
understanding of the regulatory mechanisms of the TIA pathway may be a requirement for 
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successful metabolic engineering. Despite the complicated regulation, recent research has shed 
light on this area.  
Extensive research has studied the influence of signaling molecules on TIA biosynthesis. 
Although the elucidation of the entire regulatory mechanism is not complete, those signaling 
molecules, such as jasmonate (JA), ethylene, nitrous oxide (NO), and salicylic acid, not only 
demonstrate involvement in TIA biosynthesis, but also mediate TIA production by either 
synergistic or antagonistic effects [26].  
The most direct regulation of the TIA pathway happens at the transcriptional level. 
Transcription factors, binding to a specific element and regulating the expression of genes, are a 
major mechanism controlling the biosynthetic genes of the TIA pathway. Transcription factors 
are usually regulated by signaling molecules or other elements. During the past few years, much 
effort was made to identify the transcription factors regulating the TIA pathway and to elucidate 
which genes are regulated by specific transcription factors.  
The most well-known transcription factors are the Octadecanoid-responsive 
Catharanthus AP2/ERF domain (ORCAs), including ORCA1, ORCA2, and ORCA3, which are 
members of the AP2/ERF transcription factor family. ORCA3, for which expression is inducible 
with JA and fungal elicitation, is the most widely studied. The overexpression of ORCA3 in C. 
roseus hairy roots enhanced the transcript levels of several biosynthetic genes (AS, TDC, DXS, 
CPR, G10H, SLS, STR, SGD, and D4H) involved in TIA pathway and consequently increased 
the accumulation of some TIAs [27]. Previously, overexpression of ORCA3 in C. roseus 
suspension cells also enhanced the expression of AS, TDC, DXS, CPR, STR, and D4H genes[28].  
Yeast one-hybrid screening with a Str promoter indicated that ORCA2 activates the Str 
promoter and its expression is rapidly inducible with JA and fungal elicitation;  in contrast, 
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ORCA1 is expressed constitutively and is not involved in JA- and fungal elicitor-induced Str 
gene expression  [29]. Recently, the overexpression of ORCA2 in C. roseus hairy roots enhanced 
the transcript levels of AS, TDC, G10H, STR, D4H, T16H, and PRX1 genes [30]. Besides the 
three ORCAs, another transcription factor, the C. roseus box P-binding factor (CrBPF-1) can 
also bind the Str promoter but at a different position. Research suggests that CrBPF-1 may 
enhance the expression of the Str gene when the ORCAs are already bound to the promoter [31]. 
CrMYC1 [32] and CrMYC2 [33] are basic helix-loop-helix transcription factors. Both of these 
two transcription factors are induced by JA and fungal elicitation. The mRNA levels of CrMYC1 
and Str genes were enhanced after induction by JA and fungal elicitation, which suggests that 
CrMYC1 activates the expression of the Str gene [32]. CrMYC2 is postulated to act upstream of 
ORCA2 and ORCA3, activating their transcription [33].  
ORCA2, ORCA3, CrBPF-1, CrMYC1, and CrMYC2 act as transcriptional activators for 
some TIA biosynthetic genes as well as for several transcription repressors for TIA biosynthesis. 
Three members of the Cys2/His2-type (transcription factor IIIA-type) zinc finger protein family 
from C. roseus, ZCT1, ZCT2, and ZCT3, are activated by ORCA2 and ORCA3, and repress the 
activity of the promoters of TDC and STR. In addition, the ZCT proteins can repress the 
activating activity of the AP2/ERF domain of the ORCAs [34]. In addition to the ZCT proteins, 
G-box binding factors 1 and 2 (GBF-1 and GBF-2) also act as repressors of STR gene expression 
[35]. 
CrWRKY1 and CrWRKY2 are jasmonate responsive WRKY transcription factors that 
activate several genes involved in TIA biosynthesis [36,37]. Overexpression of CrWRKY1 in C. 
roseus hairy roots up-regulated TDC, as well as the transcriptional repressors ZCT1, ZCT2, and 
ZCT3, and down-regulated the transcriptional activators ORCA2, ORCA3, and CrMYC2 [36]. In 
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contrast, overexpression of CrWRKY2 in C. roseus hairy roots led to an increase in mRNA 
transcripts of TDC, NMT, DAT, MAT , as well as both specific TIA transcriptional activators 
(ORCA2, ORCA3 and CrWRKY1) and repressors (ZCT1 and ZCT3) . 
The complex interactions of the regulation of TIA biosynthesis is summarized in Figure 
1.5. Although the isolation of transcription factors regulating the TIA biosynthetic pathway is 
progressing, further characterization of the regulatory pathways is needed. 
Transcriptional and metabolic profiling of transgenic C. roseus hairy root lines 
In order to have a better understanding of the transcriptional regulators in TIA pathway, 
we generated and characterized several transgenic C. roseus hairy root lines with different 
genotypes. The first one was overexpression of a transcriptional activator ORCA2, the second 
one was overexpression of another transcriptional activator CrBPF1, and the third one carried 
RNA interface (RNAi) constructs of two transcriptional repressors, CrGBF1 and CrGBF2. The 
time course analysis of transcript levels in those transgenic hairy root lines was characterized to 
determine the effects of those regulators on TIA biosynthetic and regulatory gene expression 
levels on time. The results from real-time PCR provided critical information about the TIA 
regulatory network, including which genes are regulated by which regulators and the timing with 
which changes in transcript levels occur. Metabolite analysis was also conducted on those hairy 
root lines. In order to profile more TIAs, heterologous expression of plant genes in yeast and 
analytical instruments, like LC-MS and NMR, were applied to prepare more in-house TIA 
standards. The results of the metabolic profiling revealed how those transcriptional regulators 
affect TIA metabolite levels. 
In addition, to study the expression status of vindoline biosynthetic pathway in hairy root, 
we co-overexpressed the first two genes, tabersonine 16-hydroxylase (T16H) and 16-
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hydroxytabersonine 16-O-methyltransferase (16OMT), catalyzing tabersonine to the first two 
intermediates in vindoline biosynthetic pathway. Again, transcriptional and metabolic profiling 
of the TIA biosynthetic pathway was done to characterize the engineered hairy root lines to have 
an intense study of the changes in the transcript and metabolite levels.  
Wax esters 
Wax esters include all the esters of fatty acids with long chain fatty alcohols (Figure 1.6). 
Based on the different melting temperatures, they are divided into either liquid waxes or solid 
waxes. The liquid waxes are used in high pressure lubricants, pharmaceutical, cosmetics, 
linoleum and printing inks industries, while the solid waxes are used in candles, polish products 
and so on. The natural sources of wax esters are extremely broad, mineral, microorganisms, 
plants and animals could contain various types of wax esters. Currently, most of wax esters are 
purified primarily from mineral oils, while the biorenewable sources of wax esters increasingly 
attract interest. 
A previous most accessible natural source for wax esters was sperm whale. In the late 
18th and early 19th centuries, sperm whale oil was used as an outstanding lubricant because of its 
low viscosity and stability, and it does not freeze down to -30°C. The compositions of sperm oil 
are mostly wax esters and a small proportion of triglyceride. The most abundant wax esters 
(mainly cetyl palmitate) is in adult males (71~94%). As the development of new lubricant being 
able to substitute the sperm oil lubricant with same performance and sperm whales being an 
endangered species because of overhunting, the US government and several other countries 
banned the whaling and the imports of whale products. From then on, the sperm oil gradually 
steps down from the stage of lubricant industry. 
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The current natural source of most wax esters is the seeds of Jojoba (Simmondsia 
chinensis). Jojoba seeds contain 50% in dry weight of wax esters which have similar structure as 
sperm whale oil and the wax esters human skin produced. Jojoba oil is mainly used in cosmetics, 
pharmaceuticals, automotives and food products. And the applications are still limited by the 
tight supply and high price of the jojoba oil. There are many other species contain relatively high 
amount of wax ester, but the yields are low so that they only have narrow applications. For 
examples, beeswax isolated from honeycomb contains 35 to 80% of wax esters, and is used in 
skin care, cosmetics and candle-making. The leaves of the carnauba palm (Copernicia cerifera) 
have a thick coating of wax esters, which is mainly used in polishing. Another type of natural 
wax esters used in cosmetics is lanolin extracted from the wool of sheep.  
Besides animal and plant species producing wax ester, some types of bacteria also 
produce wax esters naturally. They belong to Acinetobacter sp., Marinobacter sp., 
Psychrobacter sp., and Rhodococcus sp.. The most studied wax ester-producing bacterium is 
Acinetobacter baylyi (A. baylyi). A. baylyi accumulates plenty of wax esters in the existence of 
alkanes or alkanols under nitrogen-limited conditions [38]. The pathway from acyl-CoA to wax 
esters has been well characterized except that an aldehyde reductase is unknown, and the gene 
encoding bifunctional enzyme, wax ester synthase/acyl coenzyme A: diacylglycerol acyl 
transferase (WS/DGAT), has been cloned into many hosts to produce biofuels, such as fatty acid 
methyl ester or fatty acid ethyl ester. In addition, some metabolic engineering works involved in 
wax ester production were done in A. baylyi. By substituting the original acyl-CoA reductase to 
another fatty acid reductase complex LuxCDE, Santala’s group shifted the fatty alkanol chain 
length of wax esters toward shorter and more saturated ones [39].  
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Y. lipolytica 
Y. lipolytica is one of the most extensively studied oleaginous yeasts, which is capable of 
producing large amount of various metabolites and enzymes for industrial applications.  The 
advantages of using Y. lipolytica as an expression and production host is that (1) it has an intense 
secretory activity, (2) it was classified as generally recognized as safe (GRAS) by FDA, (3) 
many genetic tools have been developed in this system.  
The most important product coming from Y. lipolytica is a protein, lipase. Lipases (E.C. 
3.1.1.3) can catalyze several reactions including hydrolysis, esterification, interesterification and 
transesterification. Thus lipases have wide applications, such as detergents, substituting chemical 
surfactants [40], for the treatment of oil contaminant wastewaters [41], for the organic synthesis 
of optically active pharmaceuticals or intermediates [42], for flavor development in food industry 
[43], and in biodiesel production [44]. And the metabolic engineering and bioreactor 
fermentation works of producing lipases from Y. lipolytica were well reviewed by Fickers et al. 
[45]. Besides lipases, Y. lipolytica can also produce and secrete other endogenous enzymes, such 
as extracellular protease, alkaline protease, RNase, phosphatase, and esterase. Moreover, it is 
also an ideal expression host for heterologous protein production like laccase and epoxidase 
hydrolase. 
For the production of some organic acids in the glycolysis and TCA cycle, such as citric 
acid, isocitric acid, α-ketoglutaric acid, and pyruvic acid, Y. lipolytica presents the ability to 
produce and secrete large amount of those primary metabolites, which is comparable to most of 
the conventional commercial production fungi. The convenient genetic engineering in Y. 
lipolytica brings this fungus close to the commercial host for those organic acid productions. For 
example, Y. lipolytica has been engineered to produce comparable amount of citric acid as its 
 
13 
 
conventional producer, Aspergillus niger, and its fermentation process has been and is being 
used to produce citric acid by Archer Daniels Midland  [46-48].  
Y. lipolytica, as one of the oleaginous microorganisms, is able to produce high amount of 
microbial oils, also known as single cell oils. These oils have similar compositions as plant oils, 
and have the potential to be used in the same industrial fields as plant oils. The naturally isolated 
Y. lipolytica strains can only accumulate lipids less than 20% of cell dry weight. But now the 
lipid content in Y. lipolytica has been improved to 87% of cell dry weight, which makes it the 
rising star in oleaginous microorganisms [49]. 
In addition, Y. lipolytica have many other industrial applications. It is used to produce γ-
decalactone, a peach-like aroma compound used in food and beverages. It can also been 
employed in the bioremediation of oil-contaminated environments. The applications of Y. 
lipolytica have been discussed in several recent published reviews [50,51]. 
Production of wax esters in Y. lipolytica 
Since Y. lipolytica can accumulate large amount of lipids, together with the capability for 
high-level production of heterologous proteins and GRAS status, it becomes the ideal host of 
producing various fatty acid-based high-value bioproducts. “LipoYeasts” project in Europe 
targeted on studying and engineering Y. lipolytica to produce wax esters, hydroxylated fatty 
acids, polyhydroxyalkanoates (PHAs), carotenoids and carotenoid esters [52]. Though lots of 
efforts have been achieved in this project, so far, there is no publication on the wax esters 
production in Y. lipolytica. In one of my research projects, I introduced the pathway from acyl-
CoA to wax ester into Y. lipolytica, knocked out the substrate competitive pathway for wax 
esters, compared the effect of different FARs on wax ester production, integrated heterologous 
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genes into Y. lipolytica genome, and studied the effect of medium composition on wax ester 
production. 
Dissertation organization 
This dissertation is organized in the following manner. Chapter 1 is the introduction of 
my two studied subjects, terpenoid indole alkaloids (TIA) and wax esters. It includes the 
significances of those two types of compounds and all the reviews on TIA studies and wax ester 
productions. 
Chapter 2 describes a collaborated study on overexpressing the first two genes in the 
vindoline pathway in C. roseus hairy roots. In this chapter, we identified new metabolites in the 
transgenic hairy root lines, quantified most of the TIAs, and analyzed the transcriptional changes 
of the TIA pathway genes and regulators. The results showed that the transgenic hairy root lines 
could produce the first two metabolites in vindoline pathway, as well as some new byproducts. It 
also illustrated how the overexpression of the first two genes triggered the complex 
transcriptional responses. 
Chapter 3 is a summary of my contributions in two published papers. In this chapter, we 
studied the effects of overexpressing two transcriptional activators, ORCA2 and CrBPF1, on the 
metabolic profiles in TIA pathway. In total, time course analysis of four metabolites in the 
upstream pathway and twelve TIAs in the downstream pathway were done. And we found that 
by overexpressing those two transcriptional activators, especially ORCA2, some of the 
metabolites in TIA pathway did increase their levels to some extent at specific time points, while 
most of the metabolites kept the same level compared with controls, indicating the regulation 
mechanism is extremely complex and the TIA pathway is tightly regulated. 
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Chapter 4 details a manuscript that producing wax esters in yeast Yarrowia lipolytica. In 
this study, we knocked out some substrate competitive pathway, aiming to increase the acyl-CoA 
pool for wax ester production, and studied the effects of three different fatty acyl-CoA reductases 
(FAR), nitrogen limited fermentation on the titers and contents of wax esters. In addition, to 
avoid the plasmid instability issue, we randomly integrated FAR gene singly and combining WS 
gene into the chromosome. To date, the best titer of wax ester we got was around 550 mg/L, 
which was the highest wax ester production in microbes reported so far. 
This dissertation was under the guidance, supervision and support of my major professor, 
Zengyi Shao. 
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Table 
Table 1.1 Examples of recent metabolic engineering efforts in TIA pathway 
hosts engineering strategies role in TIA 
pathway 
expression system main observations 
native 
host 
overexpression of WRKY1 [36] transcription 
activator 
hairy root 3-fold increase in serpentine; 
10-fold increase in ajmalicine; 
2-fold decrease in catheranthine 
overexpression of ORCA3 [53] transcription 
activator 
hairy root 3-fold increase in hörhammericine; 
3-fold increase in lochnericine 
overexpression of DAT [13] pathway enzyme hairy root 4-fold increase in hörhammericine 
overexpression of Asα and Asβ, 
and feeding of 10-deoxy-D-
xylulose, loganin and secologanin 
[54]  
pathway enzyme hairy root 2.3-fold increase in hörhammericine; 
1.5-fold increase in cathenamine; 
1.3-fold increase in catharanthine; 
1.8-fold increase in ajmalicine; 
2.1-fold increase in lochnericine 
overexpression of ORCA3 and 
feeding of loganin [55] 
transcription 
activator 
suspension cell 3.2-fold increase in TIA; 
detectable strictosidine and ajmalicine 
overexpression of DAT [56] pathway enzyme plant 2-fold increase in vindoline 
overexpression of ORCA2 [57] transcription 
activator 
hairy root detectable 19-hydroxytabersonine 
after induction 
co-overexpression of ORCA3 and 
SGD [58] 
transcription 
activator and 
pathway enzyme 
hairy root 0.5-fold increase in TIA including 
serpentine, ajmalicine, catharanthine, 
tabersonine, lochnericine and 
hörhammericine 
non-
native 
hosts 
co-expression of TDC and STR, 
and feeding of secologanin [59] 
pathway enzyme tobacco 
suspension cell 
strictosidine can be detected 
co-expression of TDC and STR 
[60] 
pathway enzyme Cinchona 
officinalis hairy 
root 
1.2 mg g-1 DW of tryptamine; 
2.0 mg g-1 DW of strictosidine; 
not a stable trait 
co-expression of STR and SGD, 
and feeding of tryptamine and 
secologanin [61] 
pathway enzyme Saccharomyces 
cerevisiae 
Strictosidine (major product, 2g L-1) 
and cathenamine can be detected 
expression of most genes in 
strictosidine biosynthetic pathway 
and other genetic modifications in 
expression host [22] 
pathway enzyme Saccharomyces 
cerevisiae 
Strictosidine can be detected without 
any feeding. 
expression of the pathway from 
tabersonine to vindoline and 
feeding of tabersonine [21] 
pathway enzyme Saccharomyces 
cerevisiae 
Vindoline can be detected. 
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Figures 
 
Figure 1.1 An overview of the pathways leading to TIA biosynthesis 
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Figure 1.2 Examples of fatty acids. 
  
 
19 
 
 
Figure 1.3 Chemical structures of vinblastine, vincristine, vindesine, and vinorelbine. 
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Figure 1.4 Terpenoid indole alkaloid biosynthetic pathway. AS: anthranilate synthase; TDC: 
tryptophan decarboxylase; STR: strictosidine synthase; SGD: strictosidine β-D-glucosidase; 
6,7E: 6,7-epoxidase; 19H: 19-hydroxylase; MAT: minovincinine 19-hydroxy-O-
acetyltransferase; T16H: tabersonine 16-hydroxylase; 16OMT: 16-hydroxytabersonine-O-
methyltransferase; T3O/T3R: tabersonine 3-oxygenase and tabersonine 3-reductase; NMT: N-
methyltransferase; D4H: desacetoxyvindoline 4-hydroxylase; DAT: deacetylvindoline 4-O-
acetyltransferase; PRX1: peroxidase 1. The double arrows indicate multiple reactions; the dashed 
arrows represent uncharacterized reactions. Dashed box encloses the active pathway in root. 
Solid box encloses the active pathway in leaf.  
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Figure 1.5 Regulation map of the TIA biosynthesis pathway. MeJA: methyl jasmonic acid; SA: 
salicylic acid; JA: jasmonic acid; ET: ethylene; GA: gibberel-lic acid; the nodes with empty 
background are signaling molecules; the nodes with red background are transcriptional factors; 
the nodes with grey background are genes in TIA biosynthesis pathway; dashed lines represent 
interactions that may be direct or indirect; solid lines indicate potentially direct interactions. 
Green lines with arrows represent transactivation and red lines with bars represent 
transrepression. Note: CrWRKY2 overexpressed line has great positive effect on ZCT1, ZCT3 
but only slight positive effect on ZCT2, however, in order to make this figure clear, ZCT1, 
ZCT2, and ZCT3 are lumped.   
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Figure 1.6 Examples of wax esters.  
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CHAPTER II. EXPRESSION OF TABERSONINE 16-HYDROXYLASE AND 16-
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Abstract  
The monoterpene indole alkaloids vindoline and catharanthine, which are exclusively 
synthesized in the medicinal plant Catharanthus roseus, are the two important precursors for the 
production of pharmaceutically important anti-cancer medicines vinblastine and vincristine. 
Hairy root culture is an ideal platform for alkaloids production due to its industry scalability, 
genetic and chemical stability, and availability of genetic engineering tools. However, C. roseus 
hairy roots do not produce vindoline due to the lack of expression of the seven-step pathway 
from tabersonine to vindoline [1]. The present study describes the genetic engineering of the first 
two genes tabersonine 16-hydroxylase (T16H) and 16-O-methyl transferase (16OMT) in the 
missing vindoline pathway under the control of a glucocorticoid-inducible promoter to direct 
tabersonine toward vindoline biosynthesis in C. roseus hairy roots.  
In two transgenic hairy roots, the induced overexpression of T16H and 16OMT resulted 
in the accumulation of vindoline pathway metabolites 16-hydroxytabersonine and 16-
methoxytabersonine. The levels of root-specific alkaloids, including lochnericine, 19-
hydroxytabersonine and hörhammericine, significantly decreased in the induced hairy roots in 
comparison to the uninduced control lines. This suggests tabersonine was successfully channeled 
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to the vindoline pathway away from the roots competing pathway based on the overexpression. 
Interestingly, another two new metabolites were detected in the induced hairy roots and proposed 
to be the epoxidized 16-hydroxytabersonine and lochnerinine. It indicates the introduction of 
vindoline pathway genes in hairy roots can cause unexpected tepenoid indole alkaloids (TIA) 
profile alterations. Furthermore, the complex transcriptional changes in TIA genes and regulators 
detected by RT-qPCR point out the tight regulation of the TIA pathway in response to T16H and 
16OMT engineering in C. roseus hairy roots. 
Key words: Terpenoid indole alkaloid, vindoline pathway, metabolic engineering, 
Madagascar periwinkle, plant secondary metabolites 
Introduction  
Vinca alkaloids vinblastine and vincristine are powerful antineoplastic drugs that are 
widely used in many chemotherapy regimens for a variety of cancers [2].  They act by binding to 
intracellular tubulin which results in the inhibition of cell division by blocking mitosis [3]. The 
chirality and complexity of these chemicals make the synthesis of these drugs using chemical 
methods economically infeasible [4]. Catharanthus roseus (Madagascar periwinkle) continues to 
be the exclusive source for the industrial production of vinblastine and vincristine. The low 
yields of these dimeric monotepenoid indole alkaloids (TIAs) have motivated extensive effort to 
genetically engineer C. roseus for overproduction. Currently, the lack of tools for whole plant 
engineering, the genetic instability of the cell cultures, and the high accumulation of alkaloids in 
highly differentiated hairy roots have made hairy roots a promising system to engineer [5, 6].  
The biosynthesis of TIAs in C. roseus requires two precursors, secologanin from 
terpenoid pathway and tryptamine from indole pathway (Figure 2.1). The first alkaloid 
strictosidine synthesized by strictosidine synthase (STR) is converted to strictosidine aglycone 
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via strictosidine glucosidase (SGD) [7]. The highly active aglycone is catalyzed to corynanthe-
type alkaloids (serpentine, ajmalicine), iboga-type alkaloids (catharanthine), and aspidosperma-
type alkaloids (tabersonine, vindoline, hörhammericine) via several branched pathways [8]. 
However, the genes involved in these branched pathways are still largely unknown [9]. The 
coupling of vindoline and catharanthine produces the two pharmaceutically important bisindole 
alkaloids vinblastine and vincristine (Figure 2.1) [10]. In addition, the complex 
compartmentalization of the TIA pathway [11] spatially separates catharanthine and vindoline in 
different locations, which is one reason for the low yield of bisindole alkaloids within C. roseus.  
Catharanthine is synthesized in leaf epidermis and stored in upper cuticle, and vindoline is 
produced in laticifers and idioblast [12]. Moreover, these downstream alkaloid pathways are 
tissue specific. In C. roseus cell cultures and hairy roots cultures, the absence of vindoline 
accumulation is the major challenge to produce the desired bisindole alkaloids in these biological 
systems, but catharanthine and the vindoline precursor tabersonine do accumulate [13]. 
Tabersonine in un-differentiated cells and hairy roots is directed to 19-O-acetyhorhammericine 
instead of vindoline [14]. Recently the full seven steps catalyzing the conversions from 
tabersonine to vindoline was elucidated [15]. Engineering of this missing vindoline pathway in 
hairy roots or cell culture is now possible.  
To demonstrate the potential for the vindoline pathway to be expressed in hairy roots, we 
introduced the first two enzymes in the vindoline pathway, tabersonine 16-hydroxylase (T16H) 
and 16-O-methyl transferase (16OMT), into C. roseus hairy roots under the control of an 
inducible promoter system. The metabolic profile changes were measured after overexpressing 
T16H and 16OMT. Although no vindoline accumulation was detected due to the lack of 
expressing the later steps of the vindoline pathway in hairy roots, the catalytic products of T16H 
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and 16OMT were identified as expected in the engineered hairy roots. This is the first report of 
accumulating vindoline pathway intermediates in hairy roots. Furthermore, previous studies have 
pointed out the tight regulation of the TIA pathway based on the genetic engineering works in C. 
roseus hairy roots [16, 17]. In order to better understand how the transcription of alkaloid 
pathway genes and regulators respond to the metabolic alterations at this branch point, the 
relative mRNA levels of TIA genes including tabersonine 19-hydroxylase (T19H), 
minovincinine 19-hydroxy-O-acetyltransferase (MAT), strictosidine synthase (STR), 
strictosidine beta-glucosidase (SGD), and TIA regulators including AP2-domain DNA-binding 
proteins (ORCAs) and zinc finger proteins (ZCTs) were examined by RT-qPCR analysis in this 
study.  
Materials and Methods  
Plasmid construction and clone generation 
Plasmid pTA7002/T16H and pTA7002/16OMT were obtained from Dr. Ka-Yiu San, and 
T16H and 16OMT sequences were verified by sequencing. The sequencing results of these two 
genes matched the published sequence for T16H (GenBank: FJ647194.1) and 16OMT (GenBank: 
EF444544.1).  16OMT was cut from pTA7002/16OMT and moved to the intermediate plasmid 
pUCGALA [18] at the XhoI/SpeI site to construct pUCGALA/16OMT. 16OMT along with the 
promoter sequence GAL4-UAS was cut from pUCGALA/16OMT with restriction enzyme SbfI, 
and was constructed next to the right border in the T-DNA region of pTA7002/T16H (Figure 
2.2). The cis orientation and sequence of 16OMT in pTA7002/T16H/16OMT was further verified 
by sequencing.  Both T16H and 16OMT genes are under the control of a glucocorticoid-inducible 
promoter [19]. 
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Plasmids pTA7002/T16H/16OMT were electro-transferred into Agrobacterium rhizogenes 
ATCC15834. The presence of the plasmids was confirmed by sequencing.  The generation of 
transgenic C. roseus hairy roots was previously described [20]. Briefly, A. rhizogenes containing 
the plasmid was cultured in 6ml YEM media at 28 °C and 225 rpm for 36 h.  Forceps dipped into 
the agrobacteria were used to pinch the stem of the C. roseus seedlings. After 6 weeks, hairy 
roots protruding from the wounding sites were harvested and grown on selection plates (hairy 
roots media supplemented with 350 mg/L cefotaximine and 30 mg/L hygromycin). Hairy roots 
growing on selection media were transferred to new hairy roots plates and then adapted to liquid 
culture. 
Hairy roots culture and induction 
Hairy roots were sub-cultured every three weeks in 50 ml hairy roots media consisting of 
30 g/L sucrose, half strength Gamborg salt (Sigma-Aldrich), full strength Gamborg vitamin 
(Sigma-Aldrich) as previously described [21]. Triplicates of the transgenic hairy roots at late 
exponential growth stage (18 days after sub-culture) were treated with 3 µM inducer 
dexamethasone to induce overexpression of the genes or with an equal volume of ethanol as a 
negative control. After 72 h of induction, 300 mg fresh hairy roots were grinded with liquid 
nitrogen in a mortar and were frozen at -80 oC for RNA extraction. The remaining hairy roots 
were stored at -80 oC for further alkaloid extraction.  
Alkaloids extraction 
The cultured hairy root was lyophilized and ground with mortar and pestle. About 100 
mg of the powdered hairy root was weighed. Each of the samples was spiked with 150 μg 
vincamine as an internal standard. Metabolites were extracted in 4 ml of methanol with vortexing 
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for 2 min and sonicating for 10 min. The extracts were centrifuged at 3000 rpm for 3 min. The 
supernatant was removed and the biomass was extracted twice with 2 ml of methanol in each 
time. The combined supernatants were dried on a nitrogen evaporator. To further isolate TIAs 
from the methanol extracted mixture, the dried extract was partitioned between 2 ml of ethyl 
acetate and 2 ml of 1% HCl solution. TIAs stayed in the water phase. The ethyl acetate upper 
phase was discarded, and the pH of water phase was adjusted to 10 with ammonium hydroxide. 
When the water phase became alkaline, the solubility of TIAs in water decreased. So 2 ml of 
ethyl acetate was used to extract TIAs from the water phase. The ethyl acetate extract was dried 
on a nitrogen evaporator and re-dissolved in 500 μL of methanol. 
Metabolite standard from yeast fermentation 
A T16H gene encoding tabersonine 16-hydroxylase and a 16OMT gene encoding 16-
hydroxytabersonine-O-methyltransferase were cloned into a yeast plasmid pESC-Leu. The 
promoter and terminator for T16H ORF were PGAL1 and TCYC1. And the promoter and 
terminator for 16OMT ORF were PGAL10 and TADH1. The pESC-Leu-T16H-16OMT construct 
was transformed into Saccharomyces cerevisiae WAT11. S. cerevisiae harboring the desired 
plasmid were firstly cultured in Synthetic Defined Medium without leucine (SD-Leu) to grow 
biomass. After 48 hours, the collected S. cerevisiae WAT11 cells were inoculated into 1 L SD-
Leu with the glucose replaced by raffinoase and galactose to induce the GAL1 and GAL10 
promoters, keeping an initial OD as 0.2. And the medium was supplemented with 150 µM 
tabersonine. The medium was then extracted after another 48 hours with 1 L of ethyl acetate 
three times and concentrated with a rotary evaporator. The TIAs in the extract were isolated 
using same water and ethyl acetate partition method described in previous section.  
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Metabolites identification using LC/MS or LC/MS/MS 
The extract from S. cerevisiae WAT11 and hairy roots was analyzed with the Agilent 
Technologies 1100 series liquid chromatography (LC) system with a binary pump, a 
temperature-controlled autosampler, a photo diode array detector (PDA) coupled to an Agilent 
Technologies Mass Selective Trap SL detector equipped with a nanoflow electrospray. The 
column used to separate alkaloids was a Phenomenex Kinetex 5 μm C18 (150 × 2.1 mm). The 
flow rate was kept at 0.2 ml/min. The mobile phase was a 30:70 mixture of acetonitrile: 10mM 
ammonium acetate (pH=5) during the first 6 min. The mobile phase was linearly ramped to 
64:36 from the 6th min to the 18th min and maintained at that ratio till the 25th min. The ratio 
was then further increased to 85:15 within 5min and maintained for 20 min. In the next 5 min, 
the ratio was returned to 30:70 and the column was allowed to re-equilibrate for another 5 min.  
The mass spectrometer was operated in positive mode. Nebulizer pressure was set to 25 
psi and the dry gas (nitrogen) was heated up to 350 °C with a flow rate at 10 l/min. The m/z 
values were obtained with a full scan from 50 to 600 to detect the molecular weight of different 
TIA compounds. Most of the peaks in the spectra were identified with the comparison of 
calculated molecular weight and the comparison of retention time from available standard 
compounds. In the MS/MS mode, helium was used as the collision gas, and manual MS/MS 
programs were set up for specific time segments, which were the retention times of some TIAs. 
The m/z of the target compound was chosen in the time segment with 4 m/z window width, and 
1 voltage was applied as the amplitude of the excitation, with a 27% cutoff of the m/z of the 
precursor ion.  
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Metabolites quantification with HPLC 
Five microliters of the alkaloid extract was injected into the Waters HPLC system 
consisted of two 510 pumps, a 717plus Autosampler, and a 996 Photo Diode Array (PDA) 
detector. And we used a Phenomenex Luna 3 µm C18(2) LC column (250 × 4.6 mm) to separate 
the alkaloids. The HPLC protocol was almost the same as the LC-MS protocol, except the flow 
rate was kept at 0.5 ml/min. Ajmalicine, serpentine, catharanthine were identified and quantified 
at 254 nm with their own standard compounds (Sigma-Aldrich). Hörhammericine, lochnericine, 
tabersonine, 16-hydroxytabersonine, 16-methoxytabersonine were identified at 329 nm with their 
own standard compounds (Sigma-Aldrich or house-made), and quantified with tabersonine 
standard compound [22]. The two putative compounds, epoxidized 16-hydroxytabersonine and 
lochnerinine, were also quantified with tabersonine standard compound. 
RT-qPCR 
Total RNA was isolated from the frozen hairy root powder using TRIzol reagent 
according to manufacturer’s instructions (Ambion RNA by Life Technologies). DNA was 
removed from the sample with TURBO DNA-free according to the manufacturer’s instructions 
(Ambion RNA by Life Technologies). cDNA was synthesized from 500 ng RNA using random 
primers and GoScript reverse transcriptase according to manufacturer’s instructions (Promega). 
A ‘no-amplification control’ (without reverse transcriptase) was performed for each sample. 
cDNA was diluted 10 times to 200 μL with nuclease-free water. Each q-PCR reaction (20 μL) 
contained 1 μL diluted cDNA, 1.25 pmol/mL mixed primers, 10 μL SsoAdvanced SYBR green 
super mix (BIO-RAD) and nuclease-free water. The primers used for qPCR of T16H are 5’-
GCGGAACCTAACATTGCAGA-3’ and 5’-GCACATCAACAAGGTCCTCC-3’. The qPCR primer 
pairs for 16OMT are 5’-CTTGTTTGAGGGCTTGGCTT-3’ and 5’-
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TCAAACATGTCACCTGCAACA-3’. The primers used for the other genes were previously 
described [16]. The q-PCR amplifications were carried out in BIO-RAD CFX ConnectTM Real-
Time PCR Detection System with the program: 10 min at 95 °C, 40 cycles of 15 s at 95 °C, 1 
min at 60 °C. The relative gene expression was quantified by using the comparative threshold 
cycle CT method as previously described [23].  The 40S ribosomal protein S9 (RPS9) was used 
for the control gene [24].  
Statistical analysis  
Data were analyzed using the Student’s t-test. 
Results  
Genetic engineering of T16H and 16OMT in C. roseus hairy root 
Stems of C. roseus seedling were infected with Agrobacterium rhizogenes ATCC 15834 
carrying the plasmid pTA7002/T16H/16OMT. After selection on solid media containing 
hygromycin followed by six sub-culture cycles in liquid hairy root media, two stable transgenic 
hairy root lines #S3 and #S8 were obtained and used for further analysis. The expression of 
T16H and 16OMT were controlled by the same glucocorticoid-inducible promoter [19]. Both 
genes showed increased expression in the two induced hairy roots compared to the uninduced 
ones by RT-qPCR. In the induced #S3 hairy roots, T16H mRNA was increased 452.75±64.07 
times and 16OMT mRNA was increased 27.14±6.39 times compared to the uninduced control. 
#S8 hairy roots demonstrated a 107.45±19.16 fold increase in T16H mRNA level and 
149.61±30.12 fold increase in 16OMT after 72 h induction. Noticeably, #S3 hairy roots showed a 
much higher overexpression fold change in T16H than in 16OMT, while #S8 hairy roots revealed 
 
37 
 
a lower overexpression fold change in T16H than in 16OMT. These differences based on mRNA 
analysis by qPCR could be due to the differences in the background level of transcripts in the 
two different hairy roots lines. The significant clonal variation between these two transgenic 
hairy roots may also result from the random T-DNA insertion into the nuclear chromosome 
mediated by Agrobacterium transformation. Nevertheless, the use of the glucocorticoid inducible 
promoter system in this study allows us to investigate the effects of increased expression to that 
of the control within the same background. 
Identification of new metabolites in C. roseus hairy roots overexpressing T16H and 16OMT 
Tabersonine is an important branch point in vindoline production. In order to divert 
tabersonine into the vindoline pathway, the first two enzymes in vindoline pathway T16H and 
16OMT (Figure 2.3) were engineered into C. roseus hairy roots under the control of inducible 
promoter system. Due to the inaccessibility of TIAs intermediates 16-hydroxytabersonine and 
16-methoxytabersonine on market, we chose to use S. cerevisiae as a production host to prepare 
the standard molecules. S. cerevisiae does not naturally produce TIAs due to the lack of the 
terpenoid pathway derived from geranyl pyrophosphate (GPP) [25], therefore the separation of 
TIAs from other yeast native metabolites is much easier since the chemical structures of these 
contaminants are very different from TIAs. Functional expression of microsomal plant P450s has 
precedence in yeast [26]. In order to obtain 16-hydroxytabersonine and 16-methoxytabersonine 
standards for LC/MS, a S. cerevisiae strain WAT11 transformed with the plasmid pESC-Leu-
T16H-16OMT expressing T16H and 16OMT was fed with tabersonine. The two alkaloids, 16-
hydroxytabersonine and 16-methoxytabersonine, together with the substrate, tabersonine sharing 
the α−methyleneindoline structure, were identified in yeast extracts by LC/MS at 329 nm 
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according to their molecular weights (Figure 2.4). The yeast extracted alkaloids were 
subsequently used for analyze hairy root samples. 
By comparing the chromatograms of the induced and uninduced hairy roots extracts, four 
new peaks were detected in the induced hairy roots compared to the uninduced control (Figure 
2.4). Peak 1 and 2 in the induced roots showed the same retention time as 16-hydroxytabersonine 
and 16-methoxytabersonine from the yeast exacts. Mass to charge ratio (m/z) of peak 1 and 2 
further confirmed that peak 1 is the T16H-catalyzed product 16-hydroxytabersonine, and peak 2 
is the 16OMT-catalyzed product 16-methoxytabersonine. Interestingly, two unexpected peaks 
(Figure 2.4, peak 3 and 4) showed up in the induced hairy roots. Base on the m/z value of each 
peak, the molecular weight is 16 higher than that of 16-hydroxytabersonine and 16-
methoxytabersonine respectively, suggesting the new metabolites could likely be the oxidized 
forms of 16-hydroxytabersonine and 16-methoxytabersonine. 
The extremely low abundance of the two new TIA metabolites in the hairy roots made 
purification infeasible. In order to collect more evidences to confirm their chemical structures, 
MS/MS was performed for the two new TIAs, as well as other five related TIAs, including 
tabersonine, lochnericine, 16-hydroxytabersonine, 16-methoxytabersonine, and 19-
hydroxytabersonine (Figure 2.4c). Comparing the fragment patterns of tabersonine, 16-
hydroxytabersonine, and 16-methoxytabersonine, we could see that the modifications at the 16 
position in the indole moiety did not change the fragment patterns. There was only single 
abundant fragment ion [M+H-32]+ in each of their fragment spectra. On the other hand, the 
modifications in the terpene moiety changed the fragment patterns. For example, by adding a 
hydroxyl group at the 19 position (comparing the chromatograms of tabersonine and 19-
hydroxytabersonine in Figure 2.4c), besides the most abundant [M+H-32]+ peak, a second 
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abundant [M+H-18]+ appeared; by forming an epoxide ring between the 6 and 7 positions 
(comparing the chromatograms of tabersonine and lochnericine in Figure 2.4c), the fragment 
pattern changed dramatically, with four abundant peaks appeared ([M+H-18]+, [M+H-32]+, 
[M+H-60]+, [M+H-125]+). The fragment patterns of the two putative compounds were similar to 
the one of lochnericine, they all contained abundant [M+H-18]+, [M+H-32]+, [M+H-60]+, [M+H-
125]+ peaks, so the two unknown TIAs may have an epoxide ring occurring at the 6 and 7 
positions. Meanwhile, since the modifications at the 16 position in the indole moiety kept the 
most abundant fragment ion [M+H-32]+, the putative 6,7-epoxidized-16-hydroxytabersonine and 
6,7-epoxidized-16-methoxytabersonine contained more [M+H-32]+ fragment ion than 
lochnericine. Altogether, those pieces of evidences provided strong supporting information to 
indicate that the two unknown metabolites could be 6,7-epoxidized-16-hydroxytabersonine (peak 
3 in Figure 2.4) and 6,7-epoxidized-16-methoxytabersonine (peak 4 in Figure 2.4). In addition, 
T6,7-epoxidase (T6,7E) activity has been demonstrated in C. roseus hairy roots and this enzyme 
is responsible for generating the epoxidized derivatives of tabersonine (Figure 2.3) [27], we 
hypothesize that T6,7E can convert 16-hydroxytabersonine and 16-methoxytabersonine to 
epoxidized 16-hydroxytabersonine and epoxidized 16-methoxytabersonine (also named as 
lochnerinine).  
Quantification of alkaloids in the induced and uninduced hairy roots expressing T16H and 
16OMT 
After identifying the four new metabolites in the transgenic hairy roots expressing T16H 
and 16OMT, the yields of all the detected alkaloids in the induced and uninduced hairy roots 
were quantified by HPLC (Figure 2.5). 16-hydroxytabersonine was increased from the 
undetectable level in the uninduced hairy roots to 0.15 ± 0.88 mg/g dry weight (DW) in the 72 h 
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induced #S3 hairy roots and to 0.05 ± 0.00 mg/g DW in the induced #S8 hairy roots. The 
concentration of 16-methoxytabersonine was also increased to 0.15 ± 0.06 and 0.42 ± 0.04 mg/g 
DW after 72 h induction of T16H and 16OMT in #S3 and #S8 hairy roots respectively, while the 
uninduced control lines barely showed accumulation of 16-methoxytabersonine (Figure 2.5a). 
The induced #S3 hairy roots produced more 16-hydroxytabersonine but less 16-
methoxytabersonine than the induced #S8 hairy roots. In #S3 hairy roots, the fold increase of 
T16H transcripts was much higher than that of 16OMT after 72 h induction. Therefore the 
intermediate 16-hydroxytabersonine was accumulated possibly due to the relatively low 
expression of 16OMT. In contrast, 16-hydroxytabersonine could be rapidly converted to 16-
methoxytabersonine in the induced #S8 possibly due to the high-level expression of 16OMT in 
this hairy root line. The proposed epoxidized 16-hydroxytabersonine and lochnerinine showed 
very similar accumulation trends with 16-hydroxytabersonine and 16-methoxytabersonine, 
which further demonstrated that these two metabolites are most likely the derivatives of 16-
hydroxytabersonine and 16-methoxytabersonine.  
The metabolite levels in the 19-O-acetyhörhammericine pathway including lochnericine, 
hörhammericine and 19-hydroxytabersonine (Figure 2.3) were significantly decreased in the two 
induced hairy roots compared to the uninduced ones (Figure 2.5b). Tabersonine level was not 
changed in #S3 roots after induction, while a 26% decrease in tabersonine was observed in the 
induced #S8 hairy roots. Figure 2.6 shows the obvious accumulation of the total measured 
vindoline pathway metabolites in the induced roots and the great decrease in the total 19-O-
acetyhörhammericine pathway metabolites after overexpressing T16H and 16OMT. Such 
changes were expected because it indicates tabersonine has been converted into the desired 
intermediates in vindoline pathway and less flow was channeled to the root-specific 19-O-
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acetyhörhammericine pathway. However, the aspidosperma alkaloid pool consisting of 
tabersonine and its derivatives (including vindoline pathway intermediates) did not show 
significant changes after 72 h induction in both root lines (Figure 2.6).  This indicates that no 
additional carbon was pulled into tabersonine biosynthesis. 
Interestingly, catharanthine and ajmalicine were increased by 23% and 21% in #S8 hairy 
roots after induction, while serpentine showed 43% increase after induction in #S3 hairy roots 
(Figure 2.5c). Small but significant increases in total alkaloid pool (all measured alkaloids), 
corynanthe alkaloid pool (serpentine and ajmalicine), and iboga alkaloid (catharanthine) were 
noted in #S8 hairy roots after 72 h induction, while in #S3 lines the total alkaloid level was 
slightly reduced, and corynanthe alkaloid and iboga alkaloid levels remained unchanged after 
induction (Figure 2.6). These changes outside the tabersonine metabolic pathway may results 
from the complex regulations involved in the TIA pathway. The transcriptional changes of the 
TIA genes and regulators were therefore further analyzed by RT-qPCR. 
Transcriptional changes of the TIA pathway genes and regulators after inducing T16H and 
16OMT in C. roseus hairy roots 
Transcriptional alteration of TIA pathway genes and transcriptional factors was assessed 
in the 72 hr induced and uninduced hairy root lines using RT-qPCR (Figure 2.7). Interestingly, 
the 19-O-acetyhörhammericine pathway genes T19H and MAT were significantly down 
regulated in both #S3 and #S8 induced hairy roots compared to the uninduced control. Similarly, 
it was reported that the overexpression of the last gene DAT from vindoline pathway in C. roseus 
hairy roots can inhibit the activity of roots native MAT [28].   
From the previous studies, genetic perturbation of the TIA genes or transcription factors 
in C. roseus hairy roots caused complex transcriptional changes of the TIA pathway genes and 
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the associated regulators [16, 29, 30]. The mRNA levels of the two alkaloid pathway genes STR 
and SGD upstream of tabersonine did not show any changes after overexpressing T16H and 
16OMT in #S8 hairy roots, while SGD were up regulated in #S3 hairy roots after induction. The 
transcription of two positive regulators ORCA2 and ORCA3 were not changed in #S3 hairy roots 
after induction, while ORCA2 was up regulated and ORCA3 was down regulated in the induced 
#S8 hairy roots compare to the uninduced control. In addition, overexpression of T16H and 
16OMT also triggered the negative regulation response of TIA pathway. Notably, the negative 
TIA regulators ZCTs were greatly up regulated in both root lines after 72 h induction, with the 
only exception that ZCT3 was not changed in the induced #S3 hairy roots compared to the 
control.  
Discussion 
In this study, the first two genes T16H and 16OMT were successfully introduced into C. 
roseus hairy roots with the aim of initiating production of metabolite intermediates of the 
vindoline pathway. The induced overexpression of T16H and 16OMT resulted in the synthesis of 
16-hydroxytabersonine and 16-methoxytabersonine that are the first two intermediates in the 
vindoline pathway. Previous efforts have not identified any metabolite along the pathway from 
tabersonine to vindoline in other hairy root lines [31].  The production of these alkaloids in this 
study is the first report of these metabolites in hairy roots. Interestingly, two unknown alkaloids 
were detected in the two T16H and 16OMT induced hairy roots. The presence of unexpected 
metabolites after introducing the leaf-specific genes into hairy roots might be caused by two 
reasons: the naturally occurring metabolites were catalyzed by the newly introduced enzymes 
due to the promiscuous substrate specificity, or the catalytic products of the new enzymes were 
converted by the native enzymes. The molecular weight of the two new compounds is 16 higher 
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than that of 16-hydroxytabersonine and 16-methoxytabersonine individually. Moreover, these 
two previously unknown metabolites showed similar accumulation trends with 16-
hydroxytabersonine and 16-methoxytabersonine. Thus they are likely the oxidized form of 16-
hydroxytabersonine and 16-methoxytabersonine. In hairy roots, the tabersonine metabolic 
pathway involves four enzymes including T19H, MAT, T6,7E, and T6,7R, among which, T19H 
[14] and T6,7E [27] oxidize tabersonine and its derivatives at different positions (Figure 2.3). 
The two unknown metabolites showed similar fragmentation patterns with the tabersonine 
derivative with an epoxide ring on the 6,7 position based on MS/MS analysis (Figure 2.4c). In 
addition, feeding 16-hydroxytabersonine and 16-methoxytabersonine to S. cerevisiae WAT11 
overexpressing T19H did not result in the conversion of these two metabolites (data not shown 
here). The function of T6,7E in crude protein from hairy roots was characterized even though the 
sequence of T6,7E remains unknown. The metabolites lochnericine, hörhammericine, and 19-O-
acetyl hörhammericine are all oxygenated derivatives of tabersonine at position 6,7 which results 
from T6,7E enzyme activity [27]. Thus this root-dominant enzyme T6,7E is proposed to have a 
broader substrate specificity and contributes to the production of the two possible epoxidized 16-
hydroxytabersonine and 16-methoxytabersonine in the induced hairy roots.  
Lochnericine and hörhammericine both had significant lower levels in the induced hairy 
roots compared to the uninduced controls. This indicates that the induced T16H is competing for 
the precursor tabersonine with the root-specific enzymes T6,7E or T19H. Moreover, the down 
regulation of T19H and MAT mRNA levels after induction is also responsible for the decrease in 
the metabolites in this pathway branch.  However, it is unclear whether these down regulations 
resulted from transcription-level control. Noticeably, the vindoline pathway and the 19-O-
acetylhorhammericine pathway not only share the same precursor tabersonine, some enzymes in 
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these two pathways have certain homology in sequence or similar function. For example, MAT 
in the 19-O-acetylhorhammericine pathway shares 63% nucleic acid and 78% amino acid 
identities with DAT in the vindoline pathway [32]. They catalyze acetyl transfer reaction at 
different hydroxyl positions (Figure 2.3). T16H and T19H can hydrolyze the substrate 
tabersonine at 16 and 19 positions, respectively. T3O in vindoline pathway and T6,7E from 19-
O-acetylhorhammericine pathway both catalyze oxygenate reaction. T6,7E epoxides the double 
bound at 6,7 position of tabersonine and tabersonine derivatives. T3O oxygenates the double 
bond at position 3 of tabersonine and its derivatives. The engineering of the terminal step of 
vindoline biosynthesis DAT inhibited the activity of roots MAT in C. roseus. These results 
showed a sign of competitive relationship between the vindoline pathway and 19-O-
acetylhorhammericine pathway. The total aspidosperma alkaloids accumulation did not change 
much after overexpressing T16H and 16OMT, because the increase in metabolites in the 
vindoline pathway is compensated for the decrease in lochnericine and hörhammericine.  
Nevertheless, it indicates tabersonine flux was successfully diverted to the desired vindoline 
pathway from the root native 19-O-acetylhorhammericine pathway.   
Moreover, engineering of T16H and 16OMT also caused metabolite level changes beyond 
tabersonine metabolic pathway. The level of corynanthe and iboga alkaloids, which are alkaloids 
that diverge from a common precursor (strictosidine aglycone), increased in the induced #S8 
hairy roots, while the induced hairy roots of #S3 did not show significant changes in these two 
alkaloid pools. In addition, the total measured alkaloids showed opposite accumulating trends in 
two induced hairy roots #S3 and #S8. It is hypothesized that a much higher overexpression level 
of T16H in the induced #S3 hairy roots than that in the induced #S8 hairy roots caused a higher 
metabolic burden or a negative effect on total alkaloids accumulation.  
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Many previous C. roseus engineering studies showed that the modification of TIA genes 
usually led to complex transcriptional changes in other pathway genes and transcription factors 
[16, 17, 33]. Similarly, the complicated mRNA changes in the TIA pathway regulators were 
triggered after inducing two vindoline pathway genes T16H and 16OMT. The relative expression 
of the positive regulators, ORCAs, and the negative regulators, ZCTs, have been correlated with 
the jasmonate-dependent alkaloid biosynthesis [34]. In this study, ZCTs showed a great 
downregulation in the induced hairy roots compared to the uninduced control, while ORCAs 
revealed complex changes. The tight control of TIA biosynthesis by transcription factors is a 
strategy used by plants to balance growth and defense. In the future, a better understanding of 
how to bypass negative regulation is necessary to successfully engineer the TIA pathway for 
increased alkaloid accumulation.  
Conclusion 
The vindoline pathway derived from the precursor tabersonine is spatially regulated in C. 
roseus. The inactivity of this pathway in hairy roots and cell suspension cultures is the biggest 
barrier for the production of vindoline, vinblastine and vincristine.  In the present study, we 
describe the expression of the first two genes, T16H and 16OMT, in the vindoline pathway that 
initiates the channeling of tabersonine to vindoline pathway intermediates in C. roseus hairy root 
cultures. It is not surprising that expressing only the first two genes of the vindoline pathway is 
not sufficient to make vindoline in hairy roots.  Besides seeing the accumulation of the expected 
products of T16H and 16OMT, two additional alkaloids were produced, and the concentrations of 
other root specific metabolites were significantly changed. This study also illustrates how 
introduction of T16H and 16OMT triggered complex transcriptional responses, especially the up-
regulation of the negative transcription factors. This study provides insights regarding how to 
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express the full vindoline biosynthesis pathway to generate vindoline accumulating hairy roots. 
In the future, eliminating reactions competing for tabersonine, removing root dominant enzymes 
such as T6,7E, and silencing the negative regulators in combination with overexpressing the 
vindoline pathway will be necessary to reach industrial relevant yields of vindoline production in 
hairy roots. 
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Figures 
 
Figure 2.1 Terpene indole alkaloid pathway in C. roseus. STR, strictosidine synthase; SGD, 
strictosidine beta-glucosidase; THAS, tetrahydroalstonine synthase; T19H, tabersonine 19-
hydroxylase; MAT, minovincinine 19-hydroxy-O-acetyltransferase; T16H, tabersonine 16-
hydroxylase; 16OMT, 16-O-methyltransferase; T3O, tabersonine 3-oxygenase; T3R, tabersonine 
3-reductase; NMT, N-methyltransferase; D4H, desacetoxyvindoline 4-hydroxylase; DAT, 
deacetylvindoline-4-O-acetyltransferase; Prx1, Peroxidase 1. 
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Figure 2.2 Plasmid construct. RB, right border of T-DNA; LB, left border of T-DNA; p35S, 
cauliflower mosaic virus 35S promoter; GVG, chimeric transcription factor containing GAL4 
DNA-binding domain and VP16 transactivating domain and rat-GR HBD; E9, pea rbcS-E9 
polyadenylation terminator sequence; pNOS, nopaline synthase promoter; HPT, hygromycin 
phosphotransferase gene; tNOS, nopaline synthetase polyadenylation sequence terminator; 
p6xUAX, GVG-regulated promoter; 3A, pea rbcS-3A polyadenylation terminator sequence. 
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Figure 2.3 Tabersonine metabolism in roots and leaves. Metabolite and enzyme names showed in 
black indicate that they are naturally present in hairy roots. Blue ones represent the engineered 
enzymes and the detected metabolites after overexpressing the engineered genes in hairy roots. 
Red represents the hypothesized enzyme and metabolites after overexpressing T16H and 
16OMT. Green represents the enzymes or metabolites which are not present in the transgenic 
hairy roots. 
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(c) 
Figure 2.4 The selected LC chromatograms of alkaloid extracted from the hairy roots cell lines 
#S3 (a) and #S8 (b) induced (I) or  un-induced (UI) for 72 hr, and the selected LC-MS/MS ion 
chromatograms of the extracted alkaloids (c). YE represents alkaloids extracts from the medium 
of tabersonine-supplemented yeast cell cultures expressing pESC-Leu-T16H-16OMT. Peak 1, 16-
hydroxytabersonine. Peak 2, 16-methoxytabersonine. Peak 3, putative epoxidized 16-
hydroxytabersonine. Peak 4, putative epoxidized 16-methoxytabersonine.  
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(c) 
Figure 2.5 The alkaloid levels in the transgenic Catharanthus roseus hairy roots expressing 
T16H and 16OMT.  The two hairy roots overexpressing T16H and 16OMT (#S3-I and #S8-I) 
were induced with 3 μM dexamethasone during exponential growth phase and harvested 72 h 
later.  The controls (#S3-UI and #S8-UI) were the same root line fed with an equivalent volume 
of ethanol. HPLC analysis was used to determine the concentrations of the new metabolites: (a) 
metabolites appearing after overexpressing T16H and 16OMT (16-hydroxytabersonine, 16-
methoxytabersonine, proposed epoxidized 16-hydroxytabersonine and lochnerinine), (b) root 
aspidosperma metabolites (tabersonine, lochnericine, hörhammericine, and 19-
hydroxytabersonine) and, (c) other TIAs (serpentine, ajmalicine, catharanthine, and 
tetrahydroalstonine). “*”(p < 0.1) and “**”(p < 0.05) indicates significant results between the UI 
and I cultures. Error bars represent the standard deviation of triplicate cultures. 
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Figure 2.6 The terpenoid indole alkaloid pools in the transgenic Catharanthus roseus hairy roots 
expressing T16H and 16OMT. The hairy roots overexpressing T16H and 16OMT (#S3-I and 
#S8-I) were induced with 3µM dexamethasone during exponential growth phase and harvested 
72 h later.  The controls (#S3-UI and #S8-UI) were the same root line fed with an equivalent 
volume of ethanol. HPLC analysis was used to determine the TIA pools belong to aspidosperma 
family (tabersonine, lochnericine, hörhammericine, 16-hydroxytabersonine, 16-
methoxytabersonine, putative epoxidized 16-hydroxytabersonine and putative lochnerinine), 
vindoline pathway (16-hydroxytabersonine, 16-methoxytabersonine, putative epoxidized 16-
hydroxytabersonine and putative lochnerinine), 19-acetylhorhammericine pathway (lochnericine 
and hörhammericine), the total alkaloids (all alkaloids measured), corynanthe family (serpentine 
and ajmalicine), and iboga family (catharanthine). Error bars represent the standard deviation of 
triplicate cultures. “*”(p < 0.1) and “**”(p < 0.05) indicates significant results between the UI 
and I cultures. Error bars represent the standard deviation of triplicate cultures. 
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Figure 2.7 RT-qPCR of the TIA pathway genes and transcription factors mRNA transcripts fold 
change in the 72 h induced root line compared to the uninduced root line. Date represents the 
mean of triplicate ± standard deviation. “*” indicates significant results (p < 0.1 and two fold 
change) between the UI and I cultures. Error bars represent the standard deviation of triplicate 
cultures.  
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CHAPTER III. METABOLIC PROFILING OF CATHARANTHUS ROSEUS HAIRY ROOT 
LINES OVEREXPRESSING TRANSCRIPTION ACTIVATORS FOR TERPENOID INDOLE 
ALKALOID PATHWAY 
This chapter is revised from two published papers “The ORCA2 transcription factor plays a key 
role in regulation of terpenoid indole alkaloid pathway” and “CrBPF1 overexpression alters 
transcript levels of terpenoid indole alkaloid biosynthetic and regulatory genes”. The metabolite 
quantification work done by Shanks’ group was picked out, and I contributed in identification of 
some TIAs and their quantification. 
Le Zhao1, Guy Sander2, Jacqueline Shanks1 
1Dept. of Chemical and Biological Engineering, Iowa State University 
2Dept. of Chemical Engineering, University of Minnesota Duluth 
Introduction 
Madagascar periwinkle Catharanthus roseus produces over 130 terpenoid indole 
alkaloids (TIAs), and is a main source for several high value TIAs as pharmaceutical 
compounds. Vinblastine and vincristine are the two TIAs which were found to have anti-cancer 
functions, and have been marketed and wildly used in chemotherapeutic regents in the treatment 
of lymphoma and leukemia [1]. And so far, C. roseus is the sole host to produce vincristine and 
vinblastine. Besides, some other TIAs accumulated in C. roseus are used to treat hypertension, 
such as ajmalicine and serpentine. The current commercial production of vinblastine and 
vincristine is a conventional and low-efficient method, extraction from plant leaves. The low 
contents of the target compounds make them expensive. Though the total chemical synthesis of 
vincristine and vinblastine has been studied [2, 3], it is still not economically feasible to replace 
the plant extraction. Another alternative way to increase TIA production is through plant tissue 
and cell cultures, or even bacterial cultures. For plant tissue and cell cultures, lots of efforts have 
been done on optimizing the culture conditions and feeding all kinds of elicitors, and some 
simple metabolic engineering works have been done in hairy root culture, suspension cell 
culture, etc. Those manipulations have been reviewed in the introduction of the thesis. While for 
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heterologous production of those valuable TIAs, the studies are in their infancy and limited by 
the elucidation of the whole pathway and some deficiencies on heterologous expression, such as 
protein misfolding. As secondary metabolites, TIA pathway is highly regulated and large 
portions of the networks on metabolites, transcription factors, and genes in C. roseus are still 
unknown. To better engineer the production systems, we have to learn the pathway and the 
regulation mechanism more deeply.  
The TIA biosynthetic pathway is highly branched (Figure 3.1). The first TIA in the 
pathway, strictosidine, contains an indole moiety from tryptamine and terpene moiety from 
secologanin. The condensation reaction is catalyzed by strictosidine synthase (STR), then 
strictosidine β-D-glucosidase (SGD) deglucosylates strictosidine to strictosidine aglycone. 
Further enzymatic steps result in the formation of numerous TIAs via several branches. In 
specific, one branch of the TIA pathway leads to the production of ajmalicine and serpentine, a 
second branch produces catharanthine, and a third branch leads to an intermediate, tabersonine, 
which is a key metabolite in the TIA pathway. The metabolites derived from tabersonine are 
differentiated in different organs. The pathway from tabersonine to vindoline activates in plant 
leaves, vindoline and catharanthus are condensed by a major class III peroxidase (PRX1), and 
this leads to the production of anticancer drugs, vinblastine and vincristine. While in root, 
tabersonine is derived into many other metabolites, such as lochnericine and horhammericine.  
Transcriptional activators and repressors play importance roles in regulating TIA 
synthesis. To date, seven putative activators (ORCA2, ORCA3, CrBPF1, CrMYC1, CrMYC2, 
CrWRKY1 and CrWRKY2) and five putative repressors (ZCT1, ZCT2, ZCT3, GBF1 and 
GBF2) have been implicated as regulators of the TIA pathway. The studies on those 
transcriptional factors have been reviewed in the introduction of this thesis. ORCA2 
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(Octadecanoid-Responsive Catharanthus AP2-domain protein 2) is AP2-domain transcription 
factor that are proposed to activate STR expression by binding to the jasmonate and elicitor-
responsive element (JERE) in the STR promoter [4]. CrBPF1 was identified as a protein that 
binds to a separate element in the STR promoter through a signal transduction pathway that is 
responsive to elicitors but not jasmonate and acts downstream of protein phosphorylation and 
calcium influx [5].  
To date, there are only a few studies about ORCA2 and CrBPF1 characterization. Here 
we studied systematically on the transcriptional and metabolic effects lead by overexpression the 
two transcriptional activators separately. Our collaborated lab, Sue Gibson’s group, focused on 
the generation of the transgenic C. roseus hairy root lines and did transcription analysis of 
several transcriptional factors and genes involved in the TIA pathway on those transgenic lines. 
While in our lab, we did metabolic profiling of the TIAs on the hairy root lines. In this chapter, 
we summarized all the works have been done on the metabolic profiling part.  
Materials and Methods 
Alkaloid extraction 
Frozen hairy root tissue samples, collected as described above, were lyophilized and 
ground to a powder. Approximately 50 mg of the freeze-dried and ground hairy roots were added 
to a 50-mL centrifuge tube and extracted with 10 mL of methanol using a sonicating probe 
(Model VC 130PB, Sonics & Materials, Inc.) for 10 min while held on ice. The extracts were 
then centrifuged at 4000 rpm for 12 min at 15 °C. The supernatant was removed and the biomass 
was extracted one more time in the same manner. The combined supernatants were passed 
through a 0.45 µm nylon filter (25 mm, PJ Cobert), dried using a nitrogen evaporator 
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(Organomation Associates, Inc.), reconstituted in 2 mL of methanol, and passed through a 0.22 
µm nylon filter (13 mm, PJ Cobert) for HPLC analysis. Extracts were stored at -25 °C. 
Alkaloid analysis 
20 µL of the alkaloid extract was injected into a Phenomenex Luna C18(2) column (250 
x 4.6 mm) using three solvent systems. The Waters high performance liquid chromatography 
system consisted of a 1525 binary pump, a 717plus Autosampler, and a 996 Photo Diode Array 
(PDA) detector. For the measurement of tryptophan and tryptamine, a previously described 
method was used with UV detection at 218 nm [6]. Quantification was performed by comparison 
to standard curves. For detection of iridoid glycosides a second solvent system was used. Data 
extracted at 239 nm were used to quantify loganin and secologanin. For 30 min, at a flow rate of 
1 mL min-1, the mobile phase was linearly ramped from a 90:10 to a 75:25 mixture of 1% formic 
acid (v/v)/0.25% trichloroacetic acid (w/v):acetonitrile. The ratio was then returned to 90:10 and 
the column was allowed to re-equilibrate.  
For the detection of TIAs, a third solvent system was used. Data extracted at 254 nm 
were used to quantify strictosidine, ajmalicine, serpentine, catharanthine, vindoline, vinblastine 
and vincristine using standard curves. Data extracted at 329 nm were used to quantify 
tabersonine, hörhammericine, lochnericine, 19-hydroxytabersonine (19OHTab) and 16-
hydroxytabersonine (16OHTab) using retention time standards, photodiode array detection, and a 
comparison to a tabersonine standard curve. The retention time standards of 19OHTab and 
16OHTab were in-house prepared and the procedures were described in Chapter II. Metabolite 
levels were determined based on peak area, with the exception of loganin, which was quantified 
based on peak height. The protocol was adapted from a previously published protocol [6]. For 
the first 5 min, at a flow rate of 1 mL min-1, the mobile phase was a 30:70 mixture of acetonitrile: 
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100 mM ammonium acetate (pH 7.3). The mobile phase was linearly ramped to 64:36 over the 
next 10 min and maintained at that ratio for 15 min. The flow rate was increased to 1.4 mL min-1 
over 5 min. The ratio was then increased to 80:20 during the next 5 min and maintained for 15 
min. The flow rate and mobile phase ratio were then returned to 1 mL min-1 and 30:70 and the 
column was allowed to re-equilibrate.  
For LC-MS analysis, the Agilent Technologies 1100 series liquid chromatography (LC) 
system with a binary pump, a temperature-controlled autosampler and a diode-array detector 
mated with an Agilent MSD model SL ion trap mass spectrometer (MS). 10 µL of the alkaloid 
extract was injected into the LC-MS system with a Phenomenex Luna C18(2) 100A column 
(150×2.0mm). The LC-MS protocol is adapted from the third solvent system of HPLC methods 
for a smaller diameter of column. The mass spectrometer was operated in positive ion mode and 
full scan data was collected between 50 and 700 m/z. Operation and analyses were performed 
with ChemStation software (Agilent Technologies). The LC-MS analysis was performed at the 
W. M. Keck Metabolomics Research Laboratory. 
Results and Discussions 
Effects of ORCA2 overexpression on the metabolite levels of the TIA pathway 
ORCA2-OE line was generated expressing ORCA2 with an ethanol-inducible promoter. 
After sequencing confirmation and adaption, RT-PCR results of the engineered lines (induced 
and uninduced) and the control lines (induced and uninduced) further confirmed that ORCA2 
transcript level had been brought up in the induced ORCA2-OE line (Figure 3.2). ORCA2 
transcript levels increase dramatically after adding ethanol to ORCA2-OE root cultures, with 
ORCA2 transcript levels increasing approximately eight fold within 24 h. In comparison, ORCA2 
 
64 
 
transcript levels in the uninduced ORCA2-OE line and the ethanol-induced or uninduced control 
line are relatively low. 
To analyze the effects of ORCA2 overexpression, the levels of 17 TIA and related 
metabolites were investigated, with 13 of those metabolites found to be present at detectable 
levels in at least some of the samples analyzed .The time course analysis of those metabolites 
was tracked over a 72 hour period following 0.02% ethanol induction, and comparisons were 
made among the four lines as the ones in ORCA2 transcript level detection.  
In one of the upstream pathways for TIA synthesis, the indole pathway, tryptophan and 
tryptamine were analyzed. Tryptamine levels increase significantly within 24 h of induction and 
remain increased through 72 h. Tryptamine levels remain unchanged in the uninduced ORCA2-
OE cultures and the induced and uninduced cultures of the control line (Figure 3.3). Levels of 
tryptophan were below detection limits. In the other upstream pathway, terpenoid pathway, the 
two metabolites, loganin and secologanin, which are very close to the formation of the first TIA, 
strictosidine, were quantified. Loganin levels in induced and uninduced ORCA2-OE cultures are 
similar (Figure 3.3). In contrast, secologanin levels are somewhat variable in the ORCA2-OE 
line. Secologanin levels are significantly decreased in induced ORCA2-OE cultures relative to 
uninduced ORCA2-OE cultures at 24 and 72 h after induction, but are not significantly different 
at the other time points assayed (Figure 3.3).  
For the downstream TIA pathway, the levels of 12 TIAs from different branches were 
investigated in aliquots of the same tissue samples used to analyze transcript levels (Figure 3.4). 
Nine of these TIAs were present at detectable levels, whereas the levels of the other three TIAs 
(vindoline, vinblastine and vincristine) were below detection thresholds. In addition, a 
tabersonine-like compound, designated Unk54, was detected in the samples. The levels of 
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strictosidine, the first TIA to be formed from secologanin and tryptamine, are significantly 
reduced in the induced versus uninduced ORCA2-OE cultures within 24 h after the start of 
induction and remain reduced throughout the remainder of the 72-h time course. Ajmalicine and 
serpentine are formed via the same branch of the TIA pathway (Figure 3.1). Both ajmalicine and 
serpentine levels exhibit modestly significant increases in the induced versus uninduced 
ORCA2-OE cultures 48 h after the start of induction, but are not significantly different at the 
other time points assayed. Catharanthine, one of the precursors for vinblastine production, also 
exhibits modestly significantly higher levels 48 h after induction, but not at the other time points 
assayed. The levels of tabersonine, which is the starting material for multiple branches of the 
TIA pathway, are significantly reduced in induced versus uninduced ORCA-OE cultures within 
6 h of the start of ORCA2 induction. Tabersonine is converted via one branch of the TIA 
pathway to lochnericine and hörhammericine. Lochnericine levels are not significantly altered by 
ORCA2 overexpression, but hörhammericine levels are significantly reduced in the induced 
versus uninduced ORCA2-OE cultures at 24 and 72 h after the start of induction. Tabersonine is 
converted via a different branch of the TIA pathway to 16-hydroxytabersonine (16OHTab). 
16OHTab levels exhibit modestly significant increases in the induced versus uninduced ORCA2-
OE cultures at 48 and 72 h after the start of ORCA2 induction. Tabersonine is also converted to 
19-hydroxytabersonine (19OHTab). 19OHTab levels increase within 12 h of the start of ORCA2 
induction and remain elevated for at least 72 h. Levels of vindoline, the end metabolite of this 
branch of the TIA pathway and precursor to vinblastine production, are below detection limits. 
An un-identified metabolite, designated Unk54, was also detected in the tissue extracts. Based on 
its UV absorption spectra between 200 and 400 nm (data not shown), Unk54 is a tabersonine-like 
compound. Unk54 levels exhibit modestly significant increases in the induced versus uninduced 
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ORCA2-OE cultures at 48 h after the start of induction, but not at the other time points assayed. 
The levels of the pharmaceutically important TIAs, vinblastine and vincristine, were below 
detection limits. 
Effects of CrBPF1 overexpression on the metabolite levels of the TIA pathway 
CrBPF1-OE line was generated expressing CrBPF1 with a β-estradiol-inducible 
promoter. After sequencing confirmation and adaption, RT-PCR results of the CrBPF1 
endogenous gene and the CrBPF1 transgene from four lines (CrBPF1-OE induced line, CrBPF1-
OE uninduced line, control induced line, control uninduced line) confirmed that CrBPF1 
transcript level had been brought up in the induced CrBPF1-OE line. In specific, CrBPF1 
transgene mRNA levels increased rapidly in the CrBPF1-OE line after addition of 20 µM β-
estradiol, rising approximately 50 fold within 6 h, and remained high for at least 72 h. Un-
induced cultures of the CrBPF1-OE line exhibited much lower transcript levels for the CrBPF1 
transgene than the induced cultures, indicating that β-estradiol is necessary for high-level 
expression of the CrBPF1 transgene (Figure 3.5A). As expected, qRT-PCR reactions using a 
primer pair specific for the CrBPF1 transgene produced only a very low signal from RNA 
isolated from the control line (data not shown), which lacks the CrBPF1 transgene. Transcript 
levels for the CrBPF1 endogenous gene were not significantly affected by treatment with β-
estradiol and were similar in the CrBF1-OE and control lines (Figure 3.5B). 
For the indole pathway, an attempt was also made to analyze tryptophan and tryptamine 
levels in aliquots of the same tissue samples used to analyze gene expression. However, 
tryptophan and tryptamine levels were below the detection threshold in many of the samples. For 
the terpenoid pathway, the levels of loganin and secologanin were also determined in aliquots of 
the same tissue samples used for gene expression analyses. The addition of 20-µM β-estradiol to 
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the media caused no substantial alterations in the levels of either of these metabolites over the 
time period analyzed (Figures 3.6). 
Towards that end, the levels of ten TIA metabolites were analyzed over a 72-h period in 
the CrBPF1-OE line grown in the presence or absence of 20-µM β-estradiol, with seven of those 
metabolites being present at detectable levels (Figure 3.7). The metabolites analyzed were 
tabersonine, lochnericine, hörhammericine, catharanthine, serpentine, ajmalicine, strictosidine, 
vindoline, vincristine and vinblastine, with the levels of the last three being below the detection 
threshold. Overexpression of CrBPF1 had only modest effects on the levels of the other seven 
metabolites, with the largest statistically significant effect being ~40% lower serpentine levels in 
the induced versus un-induced CrBPF1-OE cultures at the 12-h time point. The levels of the 
same metabolites were also analyzed in the control line, at 0 and 24 h after transfer to fresh 
media with 0 or 20 µM β-estradiol. Addition of 20-µM β-estradiol to the media had little effect 
on the levels of any of the TIA metabolites analyzed in the control line (data not shown). 
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Figures 
 
Figure 3.1 TIA biosynthesis in C. roseus. Enzyme abbreviations are written in capital letters next 
to the arrow indicating the reaction catalyzed by each enzyme. The metabolites resulting from 
different enzymatic conversions are indicated by the appropriate arrows. Solid arrows represent 
single enzymatic conversions, whereas dashed arrows indicate multiple enzymatic reactions. The 
genes that were included for analysis of expression are marked in bold. 16OMT, 16-
hydroxytabersonine-O-methyl-transferase; AS, anthranilate synthase; CPR, cytochrome P450 
reductase; CYP71BJ1, CYP71 cytochrome P450 hydroxylase; D4H, desacetoxyvindoline 4-
hydroxylase; DAT, deacetylvindoline 4-O-acetyltransferase; DMAPP, dimethylallyl 
pyrophosphate; DXS, 1-deoxy-D-xylulose-5-phosphate synthase; G3P, glyceraldehyde 3-
phosphate; G10H, geraniol 10-hydroxylase; IPP, isopentenyl diphosphate; LAMT, loganic acid 
O-methyltransferase; PRX1, vacuolar class III peroxidase; SGD, strictosidine glucosidase; SLS, 
secologanin synthase; STR, strictosidine synthase; T6,7E, tabersonine 6,7-epoxidase; T16H, 
tabersonine 16-hydroxylase; TDC, tryptophan decarboxylase.   
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Figure 3.2 Time course analysis of ORCA2 expression. Results shown are the: uninduced 
ORCA2-OE line (□, solid line), 0.02% ethanol-induced ORCA2-OE line (■, solid line), 
uninduced control line (∆, dashed line) and 0.02% ethanol-induced control line (▲, dashed line). 
The relative mRNA levels are presented as ∆∆CT. ∆∆CT = ∆CTuninduced control roots at 0 h - ∆CTother, 
where ∆CT = CTORCA2 - CTEF1/UBQ11. Positive ∆∆CT values indicate that ORCA2 transcript levels 
are higher in the indicated hairy root line grown for the indicated time under the indicated 
conditions than in the uninduced control line at 0 h. Conversely, negative ∆∆CT values indicate 
that ORCA2 transcript levels are lower in the indicated hairy root line grown for the indicated 
time under the indicated conditions than in the uninduced control line at 0 h. Results are the 
average ∆∆CT value of three biological replicates, with two technical replicates for each 
biological replicate. Error bars indicate standard deviations. ** indicates that ORCA2 transcript 
levels in the induced versus uninduced ORCA2-OE cultures differed at the same time point by p 
≤ 0.01, according to Student’s t-test. Student’s t-test results for the induced versus uninduced 
cultures of the control line are not depicted. 
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Figure 3.3 Time course analysis of metabolite levels from the indole and terpenoid pathways. 
Results shown are the: uninduced ORCA2-OE line (□, solid line), 0.02% ethanol-induced 
ORCA2-OE line (■, solid line), uninduced control line (∆, dashed line) and 0.02% ethanol-
induced control line (▲, dashed line). Results for metabolite levels are the averages of three 
biological replicates. Error bars indicate standard deviations. Metabolite levels differed with: * = 
p ≤ 0.1, ** = p ≤ 0.05 according to Student’s t-test. Student’s t-test results for the induced versus 
uninduced cultures of the control line are not depicted. 
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Figure 3.4 Time course analysis of TIA metabolite levels. Levels of vindoline, vinblastine and 
vincristine were below detection thresholds. Unk54 represents a tabersonine-like compound. 
Results shown are the: uninduced ORCA2-OE line (□, solid line), 0.02% ethanol-induced 
ORCA2-OE line (■, solid line), uninduced control line (∆, dashed line) and 0.02% ethanol-
induced control line (▲, dashed line). Results are the average values of three biological 
replicates. Error bars indicate standard deviations. Levels of the indicated metabolite in the 
induced versus uninduced ORCA2-OE cultures differed at the same time point with: * = p ≤ 0.1, 
** = p ≤ 0.05 according to Student’s t-test. Student’s t-test results for the induced versus 
uninduced cultures of the control line are not depicted. 
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Figure 3.5 Time course analysis of CrBPF1 endogenous and transgene mRNA levels. CrBPF1 
transcripts produced from the endogenous CrBPF1 gene and the CrBPF1 transgene were 
quantified independently by qRT-PCR using primers specific for each gene (Supplemental Table 
4.1). As expected, the primer pair specific for transcripts produced by the CrBPF1 transgene 
yields only a very low background signal for the control line (data not shown), which lacks the 
CrBPF1 transgene. Results depicted are the following: un-induced CrBPF1-OE line (□, solid 
line), β-estradiol induced CrBPF1-OE line (■, solid line), un-induced control line (∆, dashed 
line) and β-estradiol induced control line (▲, dashed line). (A) Relative CrBPF1 transgene 
mRNA levels are indicated as ∆∆Ct. Note that CrBPF1 transgene mRNA levels were normalized 
versus CrBPF1 endogenous gene mRNA levels in the un-induced control line at 0 h rather than 
against CrBPF1 transgene mRNA levels in the un-induced control line at 0 h as the control line 
lacks the CrBPF1 transgene. (B) Relative CrBPF1 endogenous gene mRNA levels are indicated 
as ∆∆Ct. A positive ∆∆Ct value indicates that CrBPF1 endogenous gene mRNA levels are 
higher in the indicated hairy root line grown for the indicated time under the indicated conditions 
than in the un-induced control line at 0 h. Negative ∆∆Ct values indicate the reverse situation. 
Results are the average ∆∆Ct of three biological replicates, with two technical replicates per 
biological replicate. Error bars indicate standard deviations. CrBPF1 mRNA levels in the un-
induced versus induced CrBPF1-OE cultures differed at the same time point with: * = p ≤  0.05, 
** = p ≤  0.01 according to a Student’s t-test. The results of Student’s t-tests for the un-induced 
versus induced cultures of the control line are not depicted. 
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Figure 3.6 Time course analysis of metabolite levels from the terpenoid pathway. Results 
depicted are the following: un-induced CrBPF1-OE line (□, solid line), β-estradiol induced 
CrBPF1-OE line (■, solid line). Metabolite levels in the un-induced versus induced CrBPF1-OE 
cultures differed at the same time point with: * = p ≤ 0.1, ** = p ≤ 0.05 according to a Student’s 
t-test. 
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Figure 3.7 Time course analysis of TIA metabolite levels. Results depicted are the following: un-
induced CrBPF1-OE line (□, solid line) and β-estradiol induced CrBPF1-OE line (■, solid line). 
Metabolite levels shown are the following: (A) tabersonine levels, (B) lochnericine levels (C) 
hörhammericine levels, (D) catharanthine levels, (E) serpentine levels, (F) ajmalicine levels and 
(G) strictosidine levels. Results are the average values of three biological replicates. Error bars 
indicate standard deviations. Metabolite levels in the un-induced versus induced CrBPF1-OE 
cultures differed at the same time point with: * = p ≤ 0.1 according to a Student’s t-test. 
 
 
  
 
75 
 
References 
1. Gidding, C.E.M., et al., Vincristine revisited. Critical Reviews in Oncology Hematology, 
1999. 29(3): p. 267-287. 
2. Ishikawa, H., et al., Total synthesis of vinblastine, vincristine, related natural products, 
and key structural analogues. J Am Chem Soc, 2009. 131(13): p. 4904-16. 
3. Sears, J.E. and D.L. Boger, Total Synthesis of Vinblastine, Related Natural Products, and 
Key Analogues and Development of Inspired Methodology Suitable for the Systematic 
Study of Their Structure-Function Properties. Accounts of Chemical Research, 2015. 
48(3): p. 653-662. 
4. Menke, F.L.H., et al., A novel jasmonate- and elicitor-responsive element in the 
periwinkle secondary metabolite biosynthetic gene Str interacts with a jasmonate- and 
elicitor-inducible AP2-domain transcription factor, ORCA2. Embo Journal, 1999. 18(16): 
p. 4455-4463. 
5. van der Fits, L., et al., A Catharanthus roseus BPF-1 homologue interacts with an 
elicitor-responsive region of the secondary metabolite biosynthetic gene Str and is 
induced by elicitor via a JA-independent signal transduction pathway. Plant Molecular 
Biology, 2000. 44(5): p. 675-685. 
6. Peebles, C.A.M., et al., Transient effects of overexpressing anthranilate synthase alpha 
and beta subunits in Catharanthus roseus hairy roots. Biotechnology Progress, 2005. 
21(5): p. 1572-1576. 
  
 
76 
 
CHAPTER IV. PRODUCTION OF WAX ESTERS IN YEAST YARROWIA LIPOLYTICA 
This chapter is a manuscript in preparation for submission to ACS synthetic biology. I 
contributed in the majority of the work. 
Le Zhao1, Fuyuan Jing2, James Yu3, Suzanne Sandmeyer3, Jacqueline Shanks1, Zengyi Shao1 
1 Dept. of Chemical and Biological Engineering, Iowa State University 
2 Dept. of Biochemistry, Biophysics & Molecular Biology, Iowa State University 
3Dept. of Biological Chemistry, University of California, Irvine 
Introduction 
Wax esters are an important commodity and have wide applications in skincare products, 
cosmetics, inking industry, high performance lubricants, coating etc. There are some commercial 
natural sources for wax production, such as honeycomb, wool, Brazilian palm, jojoba, and sperm 
whale. Among all the natural waxes, sperm whale oil and jojoba oil are outstanding in 
lubrication, since they contain a high percentage of monounsaturated wax esters, keeping them in 
liquid form at room temperature with high oxidation stability  [1, 2]. However, whale hunting 
was banned in 1970s, making the sperm whale oil supply terminate. And the tight supply of 
jojoba oil also makes its application limited to high price/low volume additives in personal care 
products. For the synthetic wax esters, several patents reported to produce sperm whale oil-type 
or jojoba oil-type of wax esters by chemical synthesis or enzyme catalysis, using expensive plant 
oils as substrates [3-5].  
Scientists found that some bacteria, such as Acinetobacter sp., Marinobacter sp., 
Psychrobacter sp., and Rhodococcus sp., naturally accumulate wax esters in certain conditions 
[6]. The studies of those bacteria are still in their infancy due to either the uncharacterized 
pathways or the lack of genetic tools. Besides working on the native wax-producing bacteria, the 
heterologous production of wax ester in both E. coli and S. cerevisiae were also studied [7, 8]. 
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Currently, the reported best wax ester titer in microorganisms was 80 mg/L, and it was produced 
in Acinetobacter sp. ADP1 [9]. 
In this study, we chose Yarrowia lipolytica as the host to produce wax esters 
heterologously. Y. lipolytica is oleaginous yeast, naturally accumulating abundant of 
triacylglycerol (TAG). And plenty of genetic tools have been developed. By engineering Y. 
lipolytica strain, the titer of TAG reached 85 g/L [10]. The aim of this study was to explore a 
new potential host, Y. lipolytica, for wax ester production by taking advantage of its natural 
capability of lipid hyper-accumulation and the ease of genetic manipulation. 
Materials and methods 
Strains, media, and cultivation methods 
Y. lipolytica Po1f strain was obtained from ATCC. The rest of the studied Y. lipolytica 
strains were genetically modified from Po1f. Escherichia coli strain NEB5α was used for 
recombinant DNA manipulation. We used YPD or other synthetic auxotrophic yeast culture 
media to select or culture yeast cells, and used Luria broth with 100 µg/mL ampicillin to select 
and culture recombinant E. coli strains. Y. lipolytica strains were grown in glass tubes at 30 °C 
and 250 rpm for aerobic growth. E. coli strains were grown at 37 °C and 250 rpm. All chemicals 
were purchased from ThermoFisher Scientific or Sigma Aldrich. 
Gene deletion in Yarrowia lipolytica 
To knock out the gene encoding phosphatidic acid phosphohydrolase (PAP) in TAG 
biosynthetic pathway, we used Cre-Lox recombination system. LoxP-Ura3-LoxP DNA fragment 
was amplified from plasmid p3992 obtained from Dr. Suzaane Sandmeyer’s group in University 
of California, Irvine. Around 1 kb of promoter region and terminator region of the PAP gene 
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were amplified from Y. lipolytica Po1f genome as upstream and downstream homologous arms 
in the knockout fragment. Gibson assembly was applied to assemble the promoter DNA 
fragment, LoxP-Ura3-LoxP fragment, and the corresponding terminator fragment to construct 
the knockout fragment, namely Ppap-LoxP-Ura3-LoxP-Tpap (Figure 4.1). After the Ppap-LoxP-
Ura3-LoxP-Tpap cassette was constructed and sequence was confirmed, it was transferred into Y. 
lipolytica Po1f as a linear DNA fragment via chemical transformation. Colony PCR was 
conducted to select colonies in which the LoxP cassette was integrated into the right position of 
the genome. Once we got the colony with the original PAP gene substituted by the LoxP 
cassette, we transferred p3902 (gift from Suzaane Sandmeyer) containing CreA and Leu2 
selection marker into the colony to eliminate the Ura3 marker gene between two LoxP elements. 
After the chemical transformation, we spread the cells on Sc-Leu plate to maintain the CreA 
plasmid. Then we replicated colonies from the Sc-Leu plate to  Sc-Leu+FOA (1 g/L) plate to 
select the colonies with the deletion of Ura3 marker. Colony PCR was conducted to check 
whether the selected colonies have lost their Ura3 markers between LoxP elements. Then the 
confirmed strain was grown in YPD medium for many generations to lose p3902 CreA-Leu2 
plasmid. By spreading proper amount of cultured cells on YPD plate and making replicated Sc-
Leu plate, we screened out the colonies which had successfully lost p3902 plasmid. The same 
procedures were conducted to generate MFE1 knockout. 
Le3 (PEX10 knockout strain) was a gift from Yu Jiang’s lab in China. They developed 
the CRISPR protocol in Y. lipolytica and used that technique to knock out PEX10 gene [11]. 
Construction and transformation of plasmid and linear DNA 
Plasmid pLZ1 was constructed with four basic elements: an Ura3 selection marker from 
Y. lipolytica genome, ARS18 with replicative function from Y. lipolytica genome, ampicillin 
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resistance gene (bla), as well as a replicative function sequence working in E. coli. pLZ2 plasmid 
is very similar to pLZ1 plasmid, the only difference is that pLZ2 contains a Leu2 selection 
marker instead of a Ura3 selection marker. 
Genes encoding ScFAR from jojoba (Simmondsia chinensis), MmFAR from house 
mouse (Mus musculus), MhFAR from Marinobacter hydrocarbonoclasticus, and WS/DGAT 
from Acinetobacter sp. strain ADP1 were codon optimized with our in-house program and 
synthesized by Integrated DNA Technologies (IA, USA). These FARs and WS/DGAT 
expression cassettes which include a TEF1 (including TEF1 original intron) promoter and a 
CYC1 terminator were inserted into pLZ1 or pLZ2 plasmids separately to form different 
expression plasmids listed in Table 4.1. 
The constructed plasmids were transferred into E. coli NEB5α for propagation and the 
sequence of each plasmid was confirmed by DNA sequencing. Then the correct plasmids were 
extracted from E. coli separately and transferred into Y. lipolytica strains via chemical 
transformation. The constructed strains were culture in synthetic complete selective media at 30 
°C. 
Random integration of genes into Y. lipolytica 
Hygromycin phosphotransferase (HPT) gene and ura3 gene were used as selection 
markers for gene random integration into Y. liopolytica genome.  HPT gene from E. coli was 
codon optimized and synthesized together with a Leu2 minimal promoter (-94bp ~ -1bp) and a 
short synthetic terminator Tsynth8 [12]. The whole DNA sequence was confirmed after 
assembling to plasmid and being sequenced. Overlap extension PCR was used to assemble HPT 
and MhFAR, and the PCR product was chemically transferred into Y. lipolytica to allow the 
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HPT-MhFAR fragment to be randomly integrated into the genome. And the same procedure was 
applied to integrate WS-Ura3 cassette into chromosome.  
Nile Red staining and lipid separation via thin layer chromatography (TLC) 
To roughly estimate lipid production, we used Nile Red to stain the lipid composition in 
cells. We took 20 µl of cell culture and transferred it into Nunc F96 MicroWell black plate. Then 
we added 180 µl staining buffer, 40 µM Nile Red in 90% phosphate-buffered saline (PBS) and 
10% dimethyl sulfoxide (DMSO), into the 20 µl of sample, and put it in a Synergy HT 
microplate reader. The program for the microplate reader was as follows: excitation wavelength 
was 480nm, emission wavelength was 580nm, continuously shook the plate for 30 min, and 
recorded the kinetic data with 10 min interval. 
For TLC separation, we took 400 µl of cell culture and span down the cells, kept the cell 
pellet, and added 200 µl of methanol, 100 µl of hexane, and 200 µl of water one after another 
with vortex in the interval. After well mixed, we centrifuged the sample and loaded 10 µl of 
hexane layer (upper layer) to the TLC plate. C18:0FA/C18:0-ol was used as wax ester standard, 
and the TLC plate was developed with the solvent hexane/diethyl ether/acetic acid, 90/10/1, 
v/v/v. After running on TLC, we sprayed primuline solution (5 mg in 100 ml of acetone/water, 
80/20, v/v) evenly on the TLC plate with a Sigma glass sprayer, and visualized the plate under 
UV illumination. 
Total lipid extraction and analysis 
Two ml of liquid cell culture were harvested after growing for 72 hours at 30 °C, 250 
rpm. Cells were pelleted with centrifugation and the supernatant was dumped. The cell pellet was 
resuspended with 700 µl water, and then lyophilized. Cell dry weight was recorded. Proper 
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amount of internal standard, pentadecanoic acid (C15FA), was spiked into each sample. The 
following lipid extraction method was adapted from Folch method [13]. Sample was well-
dispersed in 2 ml of chloroform and 1 ml of methanol with sonication and vortex. The 
homogenate was centrifuged and 1 ml of the liquid phase was transferred into a new glass tube 
and completely dried with nitrogen evaporator. Then we used 500 µl of hexane and 500 µl of 
water to partition the dried extract. After mixing and centrifugation, 200 µl of the upper hexane 
phase containing lipids was taken out and dried. 
Before running GC-MS, samples were silylated with MSTFA reagent (Thermo 
Scientific) followed by the recommended protocol. GC-MS analysis was performed in Agilent 
Technologies gas chromatograph coupled to Agilent mass spectrometer. The GC column we 
used was a DB-Wax capillary column (15 m × 250 µm × 0.25 µm). The injection volume was 1 
µL at a carrier gas flow of 3 mL/min helium with splitless mode. The GC program was as 
follows: At first, the temperature increased from 80 °C to 230 °C linearly with a rate of 15 °C per 
minute, then elevated to 340 °C with a rate of 8.5 °C per minute, and held at 340 °C for another 7 
minutes. The mass spectrometer source temperature was tuned to 280 °C. MS data was 
processed using the Chemstation software. 
From the GC-MS data, different types of free fatty alcohols and wax esters were 
quantified with corresponding standards purchased from Nu-Check Prep, Inc. (MN, USA).  
Lipid saponification and analysis 
To quantify the total fatty acid, we needed to extract all the fatty acid group from all 
types of lipids, such as TAG, wax ester, sterol ester etc. That is called saponification. We took 
about 10 mg of freeze dried sample and added 1 ml 1 N KOH in 90% aqueous methanol, and 
reacted at 80 °C for 1 hour. After cooling to room temperature, we added 1 ml 2 N HCl to acidify 
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the solution, and then used 2 ml hexane to extract the fatty acids. We took the hexane layer 
sample, did silylation and ran GC-MS to determine the total fatty acid. The silylation protocol 
and GC-MS protocol were the same as described above.  
Copy number analysis 
To measure the copy number of WS gene on genome for DI strain or on plasmid for SI 
strain, total DNA (including genomic DNA and plasmid DNA) was extracted from Y. lipolytica 
cells following our previous protocol [14] and was quantified by real-time PCR. ACT1 gene 
encoding actins was chosen as a reference gene. The purified PCR products amplifying partial 
ACT1 gene and WS gene were used as template to construct standard curve. A 16-fold serial 
dilution of those two PCR products, ranging from 1 ng/µL to 9.5 × 10-7 ng/µL (1/1049576 
ng/µL), were prepared. Real-time PCR was performed on a StepOnePlus System (Life 
Technologies, Carlsbad, CA) using SYBR Green as the DNA dye. And the protocol was 
described previously [14]. 
Results 
Knocking out the substrate competitive pathways to increase acyl-CoA pool 
Acyl-CoA is a key metabolite in fatty acid metabolism and catabolism pathways (Figure 
4.2). Naturally, the inputs of acyl-CoA come from the fatty acid elongation pathway, the 
degradation of sterol ester, and the degradation of triacylglycerol. On the other hand, the outputs 
of acyl-CoA include that it reacts with sterol to form sterol ester; binds to glycerol molecules in a 
series way to form triacylglycerol; converts to free fatty acids; or is further degraded through 
beta-oxidation pathway. The wax ester synthetic pathway is also derived from acyl-CoA. FAR 
converts acyl-CoA to fatty alcohol, and WS combines one molecule of acyl-CoA and one 
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molecule of fatty alcohol to form a wax ester (Figure 4.3). In other words, acyl-CoA is the sole 
substrate for wax ester production.  
One of the direct strategies to improve wax ester production is to increase the substrate 
acyl-CoA pool by knocking out or knocking down the substrate competitive pathways. 
Therefore, we constructed several knockout strains based on Y. lipolytica Po1f (Table 4.1). To 
disrupt the TAG pathway, the gene encoding phosphatidic acid phsphohydrolase (PAP) was 
knocked out to form a new strain Le1. The reason we chose PAP to manipulate is that its 
substrate, phosphatidic acid (PA), is a major component of cell membranes. It has been reported 
that dysfunction of the enzymes involved in PA synthesis can result in severe defects of various 
cellular processes [15]. Based on Le1 strain, we further knocked out the gene encoding 
multifunctional beta-oxidation protein (MFE1) to construct a new strain Le2. And by knocking 
out the gene encoding peroxisome assembly protein 10 (PEX10) in Po1f, we got Le3 strain. 
Several literatures have reported that lipid accumulation increased by disrupting the β-oxidation 
pathway via knocking out either MFE1 gene or PEX10 gene [16, 17]. So we expected that the 
metabolic flux could flow to wax ester synthetic pathway by disrupting the TAG pathway and β-
oxidation pathway.  
Then we tested the fatty acid types in Po1f, Le1, Le2, and Le3 strains. Figure 4.4 showed 
that Y. lipolytica mainly produced fatty acid with 16 and 18 carbon chain lengths, both saturated 
and unsaturated ones. Though the fatty acid type distributions were slightly different among 
those four strains, they all contained a high percentage of unsaturated fatty acids. The 
unsaturated fatty acids (C16:1 ∆9, C18:1 ∆9, C18:2 ∆9∆12) took about 70% of the total fatty 
acids.  
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Heterologous expression of the wax ester synthetic pathway in the four Y. lipolytica strains 
There are two enzymes involved in the wax ester pathway, fatty acyl-CoA reductase 
(FAR) and wax synthase (WS) (Figure 4.3). The FAR and WS genes were co-expressed in the 
four Y. lipolytica strain, Po1f, Le1, Le2, and Le3, separately.  Besides comparing the wax ester 
productions and types in different host strains, we also compared the effect of three different 
FARs on wax ester production since the substrate specificity of FARs from different sources 
varies. The three FARs we studied were ScFAR from jojoba plant (Simmondsia chinensis), 
MmFAR from house mouse (Mus musculus), and MhFAR from a marinobacter (Marinobacter 
hydrocarbonoclasticus). And the WS gene we used encodes the bifunctional protein wax ester 
synthase/acyl coenzyme A (acyl-CoA):diacylglycerol acyltransferase (WS/DGAT) from 
Acinetobacter sp. strain ADP1. This enzyme has been used in several researches to produce 
biodiesel-like fuels as fatty acid ethyl esters [18, 19]. All the combinations of the engineered 
strains are listed in Table 4.1.  
Figure 4.5 summarized the titers of the total free fatty alcohols and total wax esters with 
three FARs in four host strains. Comparing the wax ester titers among the three FARs, ScFAR 
produced the least, and MhFAR accumulated the most. This was led by the compatibility of the 
original acyl-CoA types in Y. lipolytica and the substrate specificity of those FARs and 
WS/DGAT. Specifically, the main types of fatty acid produced by Y. lipolytica are C16 and C18 
saturated and unsaturated fatty acids. In previous study, WS/DGAT has a very broad substrate 
specificity towards fatty alcohol (C2 – C30) and acyl-CoA (C2 – C20), and prefers to utilize 
C14, C16, C18, and C18:1 fatty alcohols and C14, C16, C16:1, and C18 acyl-CoA [20]. This 
indicates that WS/DGAT we chose has a good compatibility with the main acyl-CoA types in Y. 
lipolytica. While for FARs, ScFAR prefers to utilize C18, C20:1, and C22:1 acyl-CoAs [21], 
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MmFAR prefers C16, C18, C18:1, C18:2 acyl-CoAs [22], and MhFAR prefers C16, C18, C20, 
C18:1 acyl-CoAs [23]. Because there is rare very long chain acyl-CoA (>C18 acyl-CoA) in Y. 
lipolytica, we observed the tiny amount of wax ester accumulation for the strains with ScFAR 
expression. Although both MmFAR and MhFAR have good compatibility with the major acyl-
CoA types in Y. lipolytica, the big difference in wax ester titers between those two types of 
strains may partially be contributed by different enzyme activities when being expressed in the 
host strains.  
In addition, comparing the performance of same FAR in different host strains, we noticed 
that Po1f, Le1, and Le3 produced relatively equivalent amount of wax esters. In strains with 
ScFAR, the order of wax ester amounts were Le1 > Po1f > Le3; while in strains expressing 
either MmFAR or MhFAR, Po1f preformed the best, followed by Le3, then Le1. But for Le2 
strain, wax ester was never detected. For knocking out the substrate competitive pathways, we 
expected a larger acyl-CoA pool leading to an increase of wax ester production, but the results 
were opposite to what we expected. A TLC analysis for the lipid distributions in Mh-Po1f, Mh-
Le1, Mh-Le2, and Mh-Le3 was then performed (Figure 4.6), and we found that those knockout 
strains had more free fatty acids than Po1f strain, indicating that the fatty acids were not in the 
acyl-CoA activated form in those knockout strains. 
Distributions of free fatty alcohol types and wax ester types produced in engineered strains 
Besides quantifying the total titers of free fatty alcohol and wax ester in the engineered 
strains, we also analyzed the distributions of different types of fatty alcohols and wax esters as 
shown in Figure 4.7 and Figure 4.8. Figure 4.7a indicated that ScFAR specifically catalyzed 
C18:0 acyl-CoA to C18:0-ol. A recent in vitro study reported that ScFAR exhibited the highest 
activity to C18:0 acyl-CoA followed by C20:1 acyl-CoA and C22:1 acyl-CoA [21]. Since Y. 
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lipolytica doesn’t contain too much very long chain acyl-CoA (>C18), that’s why we only 
observed C18:0-ol in the ScFAR strains. Figure 4.7b and 4.7c showed that MmFAR and MhFAR 
expressions led to the production of C16:0-ol, C18:0-ol, and C18:1-ol, and both are in favor of 
C18:0-ol. The distributions are partially consistent with the ones reported in literatures. MmFAR 
preferred C16:0, C18:0, C18:1, and C18:2 acyl-CoAs in insect cells [24] and MhFAR also 
preferred medium chain acyl-CoAs as C16:0, C18:0, C20:0 and C18:1 in in vitro experiments 
[23].  
For wax ester types in Figure 4.8, strains containing ScFAR mainly produced 
C18:0FA/C18:0-ol and didn’t produce any unsaturated wax ester; strains with MmFAR preferred 
to produce C18:0FA/C16:0-ol; and strains with MhFAR produced C16:0FA/C18:0-ol the most. 
All of the data showed that WS/DGAT has broad substrate specificity to those long chain acyl-
CoAs (C16 and C18) and long chain fatty alcohols (C16 and C18), which is consistent with the 
reported WS/DGAT substrate specificity [20]. Figure 4.8 also reflected that the titers of saturated 
wax esters was much higher than the titers of unsaturated wax esters, this is probably due to the 
WS/DGAT enzyme localization in Y. lipolytica. WS/DGAT from the prokaryote Acinetobacter 
sp. ADP1 most likely stayed in the cytosol of Y. lipolytica cells, whereas most of the unsaturated 
fatty acyl-CoAs stay in organelles such as endoplasmic reticulum. The access to those 
unsaturated fatty acyl-CoAs and fatty alcohols for WS/DGAT seems to be an important question 
to be answered in future studies. 
Random genome integration to avoid plasmid instability issue 
In our experiments, we used ARS18 (1.3kb) in all of the constructed plasmids [25]. 
Although in theory the centromere in ARS18 keeps the plasmid in higher mitotic stability, we 
still found serious plasmid instability issue in all the experiments: (1) The wax ester production 
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among different colonies on the same selection petri dishes were very different with large 
standard derivation; (2) The recovered strains from the frozen stocks produced much less wax 
esters compared with previous results. 
To solve the plasmid instability issue, at first, we randomly integrated MhFAR together 
with a selection marker gene encoding hygromycin phosphotransferase (HPT) into Y. lipolytica 
Po1f’s genome and kept WS/DGAT in the plasmid form with Leu2 as the selection marker 
(pLZ2-WS), and selected the transformants in Sc-Leu+200 µg/mL hygromycin B petri dishes. 
We named the strain as Single Integration (SI) strain (Table 4.1). We randomly picked 48 
colonies and cultured in Sc-Leu+200 µg/mL hygromycin B liquid medium for three days, then 
extracted total lipids and analyzed with thin layer chromatography (TLC). We found that, among 
all the 48 colonies, only 11 of them (marked with yellow color) had relatively bright and big wax 
ester spots (compared with C18:0FA/C18:0-ol wax ester standards) (Figure 4.9). We quantified 
the wax esters and free fatty alcohols in the 11 colonies via GC-MS, and their titers were shown 
in Figure 4.10a.  The titers of wax esters varied among the 11 samples probably due to the 
different locus MhFAR randomly inserted in the chromosome. Colony #35 produced the highest 
amount of wax ester (~1.16 g/L), and was about 2 fold of the best plasmid based engineered 
strain Mh-Po1f (0.57 g/L). However, the over 1 g/L titer could not be repeated any more when 
we conducted the nitrogen limited experiment for #35 SI strain (Figure 4.10b). Free fatty alcohol 
accumulated at a constant level (~80 mg/L), but the wax ester production dropped to 276 mg/L. 
It indicated that the plasmid pLZ2-WS was still not stable in the SI strain, so we decided to 
integrate the WS gene into genome, following the MhFAR random integration. 
Firstly, we lost the pLZ2-WS plasmid in the #35 colony, only leaving the MhFAR in the 
chromosome, and then randomly integrated WS together with URA3 selection marker into the 
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genome, selected the transformants in Sc-Ura petri dishes. We named this strain as Double 
Integration (DI) strain (Table 4.1). Twenty colonies were randomly picked and their total lipids 
were analyzed via TLC. Different from the SI strain, almost all of the 20 colonies produced wax 
esters (Figure 4.11), then we picked 6 from the 20 colonies, cultured them in Sc-Ura liquid 
medium and analyzed the lipid production through GC-MS. The highest wax ester titer from the 
6 colonies of DI strain was 84 mg/L (Figure 4.12a). Compared with the #35 SI strain, the 
production of wax ester was less in those DI strains (Figure 4.12b). Meanwhile, the copy number 
of WS gene was measured in both SI strain and DI strain at three time points (24, 48, 72 hours) 
(Figure 4.13). We found that the copy number of WS gene randomly integrated into the genome 
was one in the DI strain, while the copy number dropped from 2.1 (24 hours) to 1.5 (72 hours) in 
the SI strain. These results indicated that the copy number of WS gene in SI strain was greater 
than the one in DI strain, which could explain that SI strain produced more wax esters than DI 
strain did. And the decrease of the WS copy number in SI strain implied the plasmid instability 
issue.    
Nitrogen limited fermentation to optimize culture medium for wax ester production 
Research on the microbial lipid production has shown that a high carbon to nitrogen ratio 
leads to the increased production of lipids [26]. Metabolic flux analysis and lipidomics were also 
studied in Y. lipolytica under carbon limited and nitrogen limited conditions to prove lipid 
accumulation in nitrogen limited condition [27]. In this project, we studied the effect of nitrogen 
limited fermentation on wax ester production. The common synthetic complete medium contains 
20 g/L glucose and 5 g/L ammonia sulfate. We chose three concentrations of glucose, equal or 
higher than normal condition (20 g/L, 40 g/L, and 80 g/L) and three concentrations of ammonia 
sulfate (AS), equal or lower than normal condition (0.2 g/L, 1 g/L, and 5 g/L), keeping the rest of 
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medium composition same. We found that 40 g/L glucose led to the highest wax ester content 
when AS concentration varied, and 1 g/L AS also worked the best no matter how glucose 
concentration changed. In combination, the best medium composition for wax ester production 
contained 40 g/L glucose and 1 g/L AS (Figure 4.14). 
Discussions 
In this study, we investigated three FARs from different species, ScFAR from jojoba, 
MmFAR from house mouse, and MhFAR from Marinobacter hydrocarbonoclasticus. It has 
been found that MmFAR is a transmembrane protein localized in the peroxisome [24]. And 
partial evidence has shown that ScFAR is also a membrane protein associated with the 
endoplasmic reticulum (ER) [28]. Since the sources of MhFAR and WS are both prokaryote, 
MhFAR and WS stay in the cytosol when being introduced in Y. lipolytica. We think that the 
different compartments FAR and WS enzymes located in would affect the metabolite transport 
across those organelle membranes, the distribution of free fatty alcohol among the organelles and 
cytosol would have effect on wax ester production. 
On the TLC plate for analyzing lipid distributions in  the 48 SI colonies, the patterns of 
lipid distributions present several situations: (1) Colonies like #5 and #9, rarely produced any 
free fatty alcohols nor wax esters. That is probably either because the integrated MhFAR was 
inactive or because only the selective marker gene encoding HPT was completely integrated into 
the genome. (2) Colonies like #1 and #4, accumulate significantly amount of free fatty alcohols, 
but much less wax esters compared with wax standards. This is most likely caused by the 
instability of the pLZ2-WS plasmid. (3)  Some colonies accumulated less free fatty alcohols and 
less wax esters compared with other samples. For example, colony #14 produced less than 
colony #20, we think this may be led by the different genome locus of the integrated MhFAR. 
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When we constructed those substrate competitive pathway knockout strains, Le1, Le2, 
and Le3, we expected that the knockout strains produce more wax esters than the wild type strain 
Po1f, however the results contradicted to our expectation. TLC data indicated that there were 
more free fatty acid accumulated in Le1, Le2, and Le3 (Figure 4.6).  Acyl-CoA serves as the 
precursors for free fatty acids, TAG, sterol esters, and many other types of lipids (Figure 4.2). 
The TLC result indicated that the pathways derived from acyl-CoA are regulated and interact 
with each other, providing a buffer capability for acyl-CoA pool. In our case, knocking out either 
the TAG pathway or β-oxidation pathway led to the accumulation of free fatty acids, and the 
acyl-CoA pool was not increased. To further test this hypothesis, the transcription levels of the 
genes in all the acyl-CoA derived pathways could be investigated. On the other hand, TLC is a 
rough analytical method for studying lipid distribution. A more comprehensive lipid 
quantification method using HPLC-CAD (Charged Aerosol Detection) reported by several 
literatures [29, 30] and companies (DIONEX, THERMOFISHER) may provide us more clues 
how the fluxes in the lipid pathway changed in those knockout strains. 
Conclusion 
Currently, the highest wax ester titer in this study was 570 mg/L produced by Mh-Po1f. It 
was the highest wax ester production in microbes reported so far and was about 7 fold higher 
than the wax esters produced in Acinetobacter ADP1 (80 mg/L) [31]. And we found the different 
FARs had a great effect on the wax ester production, wax ester content and titer also boosted 
under certain nitrogen limited condition.  
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Table 
Table 4.1 Strains used and constructed in this study. 
Host Strain Name Genotype  
Yarrowia lipolytica host strains 
Po1f MatA, leu2-270, ura3-302, xpr2-322, axp-2 
Le1 Derived from Po1f, ∆PAP 
Le2 Derived from Po1f, ∆PAP, ∆MFE1 
Le3 Derived from Po1f, ∆PEX10 
Yarrowia lipolytica engineered strains 
Po1f background 
Sc-Po1f Po1f, leucine+, uracil+, pLZ1-ScFAR, pLZ2-WS  
Mm-Po1f Po1f, leucine+, uracil+, pLZ1-MmFAR, pLZ2-WS 
Mh-Po1f Po1f, leucine+, uracil+, pLZ1-MhFAR, pLZ2-WS 
SI Po1f, leucine+, MhFAR-HPT (integration), pLZ2-WS 
DI Po1f, uracil+, MhFAR-HPT (integration), WS-Ura3 (integration) 
Le1 background 
Sc-Le1 Le1, leucine+, uracil+, pLZ1-ScFAR, pLZ2-WS  
Mm-Le1 Le1, leucine+, uracil+, pLZ1-MmFAR, pLZ2-WS 
Mh-Le1 Le1, leucine+, uracil+, pLZ1-MhFAR, pLZ2-WS 
Le2 background 
Sc-Le2 Le2, leucine+, uracil+, pLZ1-ScFAR, pLZ2-WS 
Mm-Le2 Le2, leucine+, uracil+, pLZ1-MmFAR, pLZ2-WS 
Mh-Le2 Le2, leucine+, uracil+, pLZ1-MhFAR, pLZ2-WS 
Le3 background 
Sc-Le3 Le3, leucine+, uracil+, pLZ1-ScFAR, pLZ2-WS 
Mm-Le3 Le3, leucine+, uracil+, pLZ1-MmFAR, pLZ2-WS 
Mh-Le3 Le3, leucine+, uracil+, pLZ1-MhFAR, pLZ2-WS 
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Figures 
 
 
 
Figure 4.1 Phosphatidic acid phosphohydrolase (PAP) loxP cassette. Ppap, promoter of PAP; 
Ura3, the selection marker; Tpap, terminator of PAP. 
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Figure 4.2 The overview of the lipid metabolism and catabolism pathways. FAS, fatty acid 
synthesis; Glycerol-3-P, glycerol-3-phosphate; LPA, lysophosphatidic acid; PA, phosphatidic 
acid; DAG, diacylglycerol; TAG, triacylglycerol; FFA, free fatty acid; SE, sterol ester; FF-ol, 
free fatty alcohol; WE, wax ester; β-Oxi, beta-oxidation pathway; Genes encoding each reactions 
in the pathways are in red color; P, peroxisome; ER, endoplasmic reticulum. Acyl-CoA is 
produced from fatty acid synthesis pathway, it is involved in the TAG synthesis and SE synthesis 
in ER, and can also be converted to FFA. In addition, TAG and SE can be degraded to FFA, and 
recycle to acyl-CoA. Acyl-CoA or FFA is transferred into peroxisome, and is further degraded 
via β-oxidation pathway. The introduced wax ester pathway also utilizes acyl-CoA as sole 
precursor.  
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Figure 4.3 Wax ester biosynthetic pathway. FAR, fatty acyl-CoA reductase; WS, wax synthase. 
 
  
 
95 
 
 
Figure 4.4 Fatty acid type distributions in Po1f, Le1, Le2, and Le3 strains. Y. lipolytica mainly 
produces C16 and C18 saturated and unsaturated fatty acids. The unsaturated fatty acids (C16:1, 
C18:1, and C18:2) take 70% (in weight) of the total fatty acids. 
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Figure 4.5 Free fatty alcohol (A) and wax ester titers (B) in all the engineered strains. “Sc” 
represents ScFAR; “Mm” represents MmFAR; “Mh” represents MhFAR. The results showed 
that MhFAR strains produced the most wax esters compared with ScFAR strains and MmFAR 
strains. In most cases, parent strain Po1f produced more wax esters and free fatty alcohols than 
the knockout strains. Le2 gave trace amount of free fatty alcohols and didn’t produce any wax 
esters. 
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Figure 4.6 Thin layer chromatography analysis of lipid distribution in Mh-Po1f, Mh-Le1, Mh-
Le2, and Mh-Le3 strains. FF-ol, free fatty alcohol standard; FFA, free fatty acid standard; TAG, 
triacylglycerol standard; WE, wax ester standard. Mh-Le1, Mh-Le2, and Mh-Le3 accumulated 
more FFA than Mh-Po1f did. 
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Figure 4.7 Titers of different free fatty alcohol types in all the engineered strains. (A) are the 
fatty alcohol titers of ScFAR strains. The ScFAR strains only produced C18:0 fatty alcohol. (B) 
are the fatty alcohol titers of MmFAR strains. (C) are the fatty alcohol titers of MhFAR strains. 
Strains in both (B) and (C) accumulated C16:0, C18:0 saturated fatty alcohols and C18:1 
unsaturated fatty alcohol. 
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Figure 4.8 Titers of different wax ester types in all the engineered strains. (A) are the wax ester 
titers of ScFAR strains; (B) are the ones of MmFAR strains; (C) are the ones of MhFAR strains. 
The wax ester types are diverse among different FAR strains, and they all produced more 
saturated wax esters than unsaturated ones. 
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Figure 4.9 Thin layer chromatography of lipid distribution in 48 colonies of SI strain. std: 
C18:0FA/C18:0-ol wax ester. The lipids in colony 6, 8, 20, 22, 23, 25, 35, 36, 38, 39, 43 (marked 
in yellow color) were further analyzed via GC-MS.  
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Figure 4.10 (A) Titers of free fatty alcohols and wax esters produced in the 11 colonies of SI 
strain. Colony #35 produced the highest titer of wax esters (1100 mg/L), and its free fatty alcohol 
titer was 70 mg/L. (B) Free fatty alcohol titer (~80 mg/L)  and wax ester titer (~270 mg/L) of 
colony #35 dropped in the later fermentation experiment. 
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Figure 4.11 Thin layer chromatography of lipid distribution in 20 colonies of DI strain. std: 
C18:0FA/C18:0-ol wax ester. The lipids in colony 1, 2, 3, 6, 7, 9 (marked in yellow color) were 
further analyzed via GC-MS. 
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Figure 4.12 (A) Titers and contents of wax esters produced by 6 colonies of DI strain. Colony 6 
produced highest amount of wax esters (84mg/L). (B) DI strains produced about 1/4 of the wax 
ester titer in SI #35 strain. 
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Figure 4.13 Copy numbers of WS gene in SI and DI strains. In DI strain, the genome contained 
one copy of WS gene; while in SI strain, the copy number of the WS gene or the plasmid 
decreased from 2.1 (24 hour) to 1.5 (72 hour).  
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Figure 4.14 Wax ester titer (A) and content (B) in SI strain #35 under different glucose and 
ammonium sulfate concentration. AS, ammonium sulfate. The highest wax ester titer and content 
were both achieved under 40 g/L glucose and 1 g/L AS condition. 
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CHAPTER V. SUMMARY 
There are two complex metabolic pathways involved in my research projects, one is TIA 
pathway in C. roseus, and the other one is lipid pathway in Y. lipolytica. The commonality in 
these two distinct pathways is that they both involve one key metabolite: for TIA pathway, 
tabersonine is the key metabolite; and for lipid pathway, acyl-CoA is the key metabolite. The 
characteristics of these two key metabolites are: (1) the pathways derived from the key 
metabolites are highly branched; (2) the key metabolites are tightly regulated. For example, in 
Figure 2.5b, the tabersonine level kept constant in both induced hairy root lines and uninduced 
hairy root lines. It is also reported by various literature that acyl-CoA is tightly regulated in many 
organisms [1, 2]. In the wax ester project, we conjectured that the reason for low wax ester 
production in knockout strains was the tightly regulated acyl-CoA.  
One of the research goals for my projects is to increase the metabolic flux to selected 
high-value products derived from the key metabolites. The “push and pull” strategy of pathway 
engineering has been considered in the projects. “Push” means to increase the precursor pools, 
and in my projects the precursors are tabersonine and acyl-CoA. “Pull” means to improve the 
enzyme conversion capability in the target biosynthetic pathways, such as the enzymes in the 
vindoline pathway and the ones in the wax ester pathway. 
For the “push” strategy, we knocked out a few competitive pathways in the wax ester 
project, but did not observe expected improvement of wax ester production, which indicated the 
acyl-CoA pool may not be increased. In the TIA projects, we overexpressed a few transcriptional 
activators and knocked down a few transcriptional repressors, expecting to increase the TIA 
metabolite levels, but the TIA levels either kept constant or went up in transient, especially 
tabersonine level was not changed. All these results indicated that the “push” strategy was not 
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working efficiently, presumably mainly because the key metabolites, acyl-CoA and tabersonine, 
are tightly regulated. The multiple outputs of the key metabolites make it challenging to lead the 
flux to the desired pathways. 
For the “pull” strategy, we found that the expression of three FARs from different 
sources affected wax ester titer significantly. And in the TIA projects, overexpression of the first 
two enzymes in the vindoline pathway also drove the metabolic flux to the vindoline pathway 
efficiently. All these data showed that improving enzyme conversion in the target biosynthetic 
pathways is an efficient way to enhance the flux to products. 
In conclusion, the “pull” strategy is more applicable than the “push” strategy in these two 
distinct cases, and it suggests a direction for future research. Specifically in the wax ester project, 
improving the FAR and WS enzyme activities would be an effective strategy to further improve 
the wax ester production. 
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